ORIGINAL_ARTICLE
Evaluation of Color and Width of Attached Gingiva Gain in Two Surgical Techniques: Free Gingival Graft and Connective Tissue Graft Covered By Thin Mucosal Flap, a Clinical Trial
Statement of the Problem:The periodontal health and marginal stability of gingiva can be negatively affected by a number of dental conditions in association with deficiency of attached gingiva. Purpose: This study aimed to compare the color and width of tissue grafted by two surgical techniques of keratinized gingival augmentation, namely free gingival graft(FGG) and connective tissue graft (CTG) covered by thin mucosal flap . Materials and Method: This clinical trial was performed on 15 adult individuals. The patients showed less than 2mm keratinized gingiva on two different recipient sides. One side was to be treated with CTG as the test group and the other side to be treated with FGG as the control group. The amount of keratinized gingiva before the surgery, size of grafted tissue during the surgery and 6 month after the surgery was documented. Six months after healing, the test and control sides were compared in terms of the width of generated gingiva on both sides, and the color match of the grafted areas with the surrounding gingiva or mucosa. The color of the grafted areas was determined and compared by using both professional evaluation and digital evaluation. Results: In digital evaluation, ∆E (which shows color mismatch) was higher in FGG. In professional evaluation, visual analogue scale (VAS) was used by two blinded periodontists. The mean VASin FGG was less than CTG. The mean increase of gingival width was higher in CTG. The increased width in CTG technique was more than that in FGG technique. This difference was statistically, but not clinically, significant. Conclusion: Higher ∆E in control side and higher mean VAS CTG both showed better color adaptation of CTG side. FGG can be used in case of increasing keratinized gingiva, vestibular depth, and in patients with low smile line without esthetic concerns. However, using connective tissue in the underlying thin mucosal layer is preferred for gingival augmentation if there are adequate vestibule depth and esthetic concerns, like in maxillary canine.
https://dentjods.sums.ac.ir/article_44916_b8b224099ec5fb0a71f6cbf8b30ca79a.pdf
2019-12-01
224
231
10.30476/dentjods.2019.44916
Color
Connective tissue
Reconstructive Surgical Procedures
Surgery
Plastic
Periodontal disease
Esthetics
Dental
Saeed
Raoofi
raoofis@yahoo.com
1
Dept. of Periodontology, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
AUTHOR
Seyedeh Mohadeseh
Asadinejad
mohadesehasadinejad@gmail.com
2
Dept. of Periodontology, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
LEAD_AUTHOR
Hooman
Khorshidi
khorshidih@sums.ac.ir
3
Dept. of Periodontology, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
AUTHOR
1. Agudio G, Cortellini P, Buti J, Pini Prato G. Periodontal Conditions of Sites Treated With Gingival Augmentation Surgery Compared With Untreated Contralateral Homologous Sites: An 18- to 35-Year Long-Term Study. J Periodontol. 2016; 87: 1371–1378. [PubMed] [Google Scholar]
1
2. Kim DM, Neiva R. Periodontal soft tissue non-root coverage procedures: a systematic review from the AAP Regeneration Workshop. J Periodontol. 2015; 86(2 Suppl): S56–S72. [PubMed] [Google Scholar]
2
3. Wennström JL. Commentary: Treatment of periodontitis: effectively managing mucogingival defects. J Periodontol. 2014; 85: 1639–1641. [PubMed] [Google Scholar]
3
4. Zigdon H, Machtei EE. The dimensions of keratinized mucosa around implants affect clinical and immunological parameters. Clin Oral Implants Res. 2008; 19: 387–392. [PubMed] [Google Scholar]
4
5. Scheyer ET, Sanz M, Dibart S, Greenwell H, John V, Kim DM, et al. Periodontal soft tissue non-root coverage procedures: a consensus report from the AAP Regeneration Workshop. J Periodontol. 2015; 86(2 Suppl): S73–S76. [PubMed] [Google Scholar]
5
6. Lang NP, Lindhe J. Clinical Periodontology and Implant Dentistry. 6th ed. John Wiley & Sons : New Jersey; 2015. [Google Scholar]
6
7. Camargo PM, Melnick PR, Kenney EB. The use of free gingival grafts for aesthetic purposes. Periodontol 2000. 2001; 27: 72–96. [PubMed] [Google Scholar]
7
8. Griffin TJ, Cheung WS, Zavras AI, Damoulis PD. Postoperative complications following gingival augmentation procedures. J Periodontol. 2006; 77: 2070–2079. [PubMed] [Google Scholar]
8
9. Shah R, Thomas R, Mehta DS. Recent modifications of free gingival graft: A case series. Contemp Clin Dent. 2015; 6: 425–427. [PMC free article] [PubMed] [Google Scholar]
9
10. Cortellini P, Tonetti M, Prato GP. The partly epithelialized free gingival graft (pe-fgg) at lower incisors. A pilot study with implications for alignment of the mucogingival junction. J Clin Periodontol. 2012; 39: 674–680. [PubMed] [Google Scholar]
10
11. Karring T, Lang NP, Löe H. The role of gingival connective tissue in determining epithelial differentiation. J Periodontal Res. 1975; 10: 1–11. [PubMed] [Google Scholar]
11
12. Lopes TR, Machado CN, Rogacheski MC, Verbicaro T, Giovanini AF, Deliberador TM. Aesthetic improvements in free gingival graft due to its association with frenectomy. RSBO (online) 2013; 10: 135–142. [Google Scholar]
12
13. Donn BJ Jr. The free connective tissue autograft: a clinical and histologic wound healing study in humans. J Periodontol. 1978; 49: 253–260. [PubMed] [Google Scholar]
13
14. Bouchard P, Malet J, Borghetti A. Decision-making in aesthetics: root coverage revisited. Periodontol 2000. 2001; 27: 97–120. [PubMed] [Google Scholar]
14
15. Burak AK. Color distribution of gingiva created by color schema maker software. East J Med. 2016; 21: 69–74. [Google Scholar]
15
16. Ho DK, Ghinea R, Herrera LJ, Angelov N, Paravina RD. Color Range and Color Distribution of Healthy Human Gingiva: a Prospective Clinical Study. Sci Rep. 2015; 5: 18498. [PMC free article] [PubMed] [Google Scholar]
16
17. Raoofi S. Inductive effect of keratinized connective tissue on overlying alveolar mucosa by underlying connective tissue. Thesis for post graduation, Mashhad University of Medical Science. 1371-72. pp. 20–35. [Google Scholar]
17
18. Goshtasbpour M, Kiani F. Evaluation of inductive effect of palatal connective tissue on alveolar mucosa after subepithelial connective tissue graft: a clinical & histological study. J Shiraz Univ Med Scien. 2000; 2: 9–20. [Google Scholar]
18
19. Silva CO, Ribeiro Edel P, Sallum AW, Tatakis DN. Free gingival grafts: graft shrinkage and donor-site healing in smokers and non-smokers. J Periodontol. 2010; 81: 692–701. [PubMed] [Google Scholar]
19
20. Lang NP, Lindhe J. Clinical Periodontology and Implant Dentistry. 6th ed. John Wiley & Sons: New Jersey; 2015. [Google Scholar]
20
21. Thoma DS, Buranawat B, Hämmerle CH, Held U, Jung RE. Efficacy of soft tissue augmentation around dental implants and in partially edentulousareas: a systematic review. J Clin Periodontol. 2014; 41 Suppl 15: S77–S91. [PubMed] [Google Scholar]
21
22. Batal H, Yavari A, Mehra P. Soft tissue surgery for implants. Dent Clin North Am. 2015; 59: 471–491. [PubMed] [Google Scholar]
22
23. Ioannou AL, Kotsakis GA, McHale MG, Lareau DE, Hinrichs JE, Romanos GE. Soft Tissue Surgical Procedures for Optimizing Anterior Implant Esthetics. Int J Dent. 2015; 2015: 740764. [PMC free article] [PubMed] [Google Scholar]
23
ORIGINAL_ARTICLE
The Effect of Platelet-Rich Fibrin (PRF), Plasma Rich in Growth Factors (PRGF), and Enamel Matrix Proteins (Emdogain) on Migration of Human Gingival Fibroblasts
Statement of the Problem:Platelet preparations such as plasma rich in growth factors (PRGF), platelet-rich fibrin (PRF), or enamel matrix proteins(Emdogain) are commonly used for soft and hard tissue regeneration. However, their comparative effectiveness has not been extensively studied, and a consensus has yet to be reached on their efficacy. Purpose:The aim of this in vitro study was to compare the effect of PRF, PRGF, and Emdogain on the proliferation of human gingival fibroblasts (HGF). Materials and Method: Artificial wounds were made in HGF cell culture after the fibroblasts reached nearly 100% of confluence. The study groups included leukocyte and platelet-rich fibrin (LPRF), pure platelet-rich fibrin (PPRF), PRGF and Emdogain. Stained cells were photographed at 48 h and one week and the percent of wound filling was measured. Statistical analysis was performed by one-way ANOVA and p values < 0.05 were considered statistically significant. Results: The highest wound filling percentages at both time intervals were observed in the PPRF group, followed by the PRGF. The lowest percentage of wound healing among test groups was observed in the LPRF while Emdogain yielded modest results. However, statistical analysis showed similar wound healing values in PRGF, PPRF, and Emdogain groups. Conclusion:Within the limitations of this study, PRGF, PPRF, and Emdogain were similarly effective in enhancing the fibroblast proliferation and artificial wound closure.
https://dentjods.sums.ac.ir/article_44917_efc566a1675a06f673b4f9040e79105d.pdf
2019-12-01
232
239
10.30476/dentjods.2019.44917
● Platelet
rich plasma ● PRF ● Enamel matrix proteins ● Fibroblast ● Wound Healing
Mohammad Reza
Talebi Ardakani
m_talebi_2002@yahoo.com
1
Dept. of Periodontics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
AUTHOR
Mansour
Meimandi
mmeimandi@dent.sbmu.ac.ir
2
Dept. of Periodontology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
AUTHOR
Reza
Shaker
shima_g22@yahoo.com
3
Periodontist, Private Practice, Tehran, Iran.
AUTHOR
Shima
Golmohammadi
shimag221@gmail.com
4
Dept. of Periodontics, Lorestan University of Medical Sciences, Khorramabad, Iran.
LEAD_AUTHOR
1. Wang HL, Greenwell H, Fiorellini J, Giannobile W, Offenbacher S, Salkin L, et al. Position paper on periodontal regeneration. J Periodontol. 2005; 76: 1601–1622. [PubMed] [Google Scholar]
1
2. Plachokova AS, van den Dolder J, Stoelinga PJ, Jansen JA. The bone regenerative effect of platelet-rich plasma in combination with an osteoconductive material in rat cranial defects. Clin Oral Implants Res. 2006; 17: 305–311. [PubMed] [Google Scholar]
2
3. Arnoczky SP, Tarvin GB, Marshall JL. Anterior cruciate ligament replacement using patellar tendon. An evaluation of graft revascularization in the dog. J Bone Joint Surg Am. 1982; 64: 217–224. [PubMed] [Google Scholar]
3
4. Kawase T, Okuda K, Yoshie H, Burns DM. Cytostaticaction of enamel matrix derivative (EMDOGAIN) on human oral squamous cellcarcinoma-derived SCC25 epithelial cells. J Periodontal Res. 2000; 35: 291–300. [PubMed] [Google Scholar]
4
5. Ivanovski S. Periodontal regeneration. Aust Dent J. 2009; 54 Suppl 1: S118–S128. [PubMed] [Google Scholar]
5
6. Cate AR, Deporter DA. The degradative role of the fibroblast in the remodelling and turnover of collagen in soft connective tissue. Anat Rec. 1975; 182: 1–13. [PubMed] [Google Scholar]
6
7. Götz W, Gerber T, Michel B, Lossdörfer S, Henkel KO, Heinemann F. Immunohistochemical characterization of nanocrystalline hydroxyapatite silica gel (NanoBone(r)) osteogenesis: a study on biopsies from human jaws. Clin Oral Implants Res. 2008; 19: 1016–1026. [PubMed] [Google Scholar]
7
8. Moharamzadeh K, Brook I, Van Noort R. Biocompat-ibility of Resin-based Dental Materials. Materials. 2009; 2: 514. [Google Scholar]
8
9. Slavkin HC, Boyde A. Cementun: an epithelial secretory product? . J Dent Res. 1975;53:157. [Google Scholar]
9
10. Simmer JP, Fincham AG. Molecular mechanisms of dental enamel formation. Crit Rev Oral Biol Med. 1995; 6: 84–108. [PubMed] [Google Scholar]
10
11. Hammarström L. Enamel matrix, cementum development and regeneration. J Clin Periodontol. 1997; 24(9 Pt 2): 658–668. [PubMed] [Google Scholar]
11
12. Sculean A, Chiantella GC, Windisch P, Donos N. Clinical and histologic evaluation of human intrabony defects treated with an enamelmatrix protein derivative (Emdogain) Int J Periodontics Restorative Dent. 2000; 20: 374–381. [PubMed] [Google Scholar]
12
13. Giannobile WV, Somerman MJ. Growth and amelogenin-like factors in periodontal wound healing. A systematic review. Ann Periodontol 2003; 8: 193–204. [PubMed] [Google Scholar]
13
14. Hammarström L, Heijl L, Gestrelius S. Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J Clin Periodontol. 1997; 24(9 Pt 2): 669–677. [PubMed] [Google Scholar]
14
15. Gestrelius S, Andersson C, Lidström D, Hammarström L, Somerman M. In vitro studies on periodontal ligament cells and enamel matrix derivative. J Clin Periodontol. 1997; 24(9 Pt 2): 685–692. [PubMed] [Google Scholar]
15
16. Zeldich E, Koren R, Nemcovsky C, Weinreb M. Enamel matrix derivative stimulates human gingival fibroblast proliferation via ERK. J Dent Res. 2007; 86: 41–46. [PubMed] [Google Scholar]
16
17. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998; 85: 638–646. [PubMed] [Google Scholar]
17
18. Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of futuresites for implants. Int J Oral Maxillofac Implants. 1999; 14: 529–535. [PubMed] [Google Scholar]
18
19. Aghaloo TL, Moy PK, Freymiller EG. Evaluation of platelet-rich plasma in combination with anorganic bovine bone in the rabbit cranium: a pilot study. Int J Oral Maxillofac Implants. 2004; 19: 59–65. [PubMed] [Google Scholar]
19
20. Kevy S, Jacobson M. Preparation of growth factor enriched autologous platelet gel. Proceeding of the 27th annual meeting of services Biomaterials 2001. Available at: [https://www.nlm.nih.gov/privacy.html. ]
20
21. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost. 2005; 3: 1894–1904. [PubMed] [Google Scholar]
21
22. Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod . 2006; 101: e56–e60. [PubMed] [Google Scholar]
22
23. Dohan Ehrenfest, DM Choukroun, J Diss, A Dohan, SL Dohan, AJ Mouhyi, J Gogly. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technologicalconcepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 101: e37–e44. [PubMed] [Google Scholar]
23
24. Schilephake H. Bone growth factors in maxillofacial skeletal reconstruction. Int J Oral Maxillofac Surg. 2002; 31: 469–484. [PubMed] [Google Scholar]
24
25. Tuan TL, Song A, Chang S, Younai S, Nimni ME. In vitro fibroplasia: matrix contraction, cell growth, and collagen production of fibroblasts cultured in fibrin gels. Exp Cell Res. 1996; 223: 127–134. [PubMed] [Google Scholar]
25
26. He L, Lin Y, Hu X, Zhang Y, Wu H. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009; 108: 707–713. [PubMed] [Google Scholar]
26
27. Liang CC1, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cellmigration in vitro. Nat Protoc. 2007; 2: 329–333. [PubMed] [Google Scholar]
27
28. Anitua E, Sánchez M, Nurden AT, Nurden P, Orive G, Andía I. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol. 2006; 24: 227–234. [PubMed] [Google Scholar]
28
29. Anitua E, Sánchez M, Orive G, Andía I. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials. 2007; 28: 4551–4560. [PubMed] [Google Scholar]
29
30. El-Sharkawy H1, Kantarci A, Deady J, Hasturk H, Liu H, Alshahat M, Van Dyke. Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. J Periodontol. 2007; 78: 661–669. [PubMed] [Google Scholar]
30
31. Woodall J Jr, Tucci M, Mishra A, Asfour A, Benghuzzi H. Cellular effects of platelet rich plasmainterleukin1 release from prp treatedmacrophages. Biomed Sci Instrum. 2008; 44: 489–494. [PubMed] [Google Scholar]
31
32. Creeper F, Lichanska AM, Marshall RI, Seymour GJ, Ivanovski S. The effect of platelet-rich plasma on osteoblast and periodontal ligament cell migration, proliferation and differentiation. J Periodontal Res. 2009; 44: 258–265. [PubMed] [Google Scholar]
32
33. Vahabi S, Vaziri S, Torshabi M, Rezaei Esfahrood Z. Effects of Plasma Rich in Growth Factors and Platelet-Rich Fibrin on Proliferation and Viability of Human Gingival Fibroblasts. J Dent (Tehran) 2015; 12: 504–512. [PMC free article] [PubMed] [Google Scholar]
33
34. Dohan Ehrenfest DM, Diss A, Odin G, Doglioli P, Hippolyte MP, Charrier JB. In vitro effects of Choukroun's PRF (platelet-rich fibrin) on human gingival fibroblasts, dermal prekeratinocytes, preadipocytes, and maxillofacial osteoblasts in primary cultures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009; 108: 341–352. [PubMed] [Google Scholar]
34
35. Liu Y, Kalén A, Risto O, Wahlström O. Fibroblast proliferation due to exposure to a platelet concentrate in vitro is pH dependent. Wound Repair Regen. 2002; 10: 336–340. [PubMed] [Google Scholar]
35
36. Graziani F, Ivanovski S, Cei S, Ducci F, Tonetti M, Gabriele M. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin Oral Implants Res. 2006; 17: 212–219. [PubMed] [Google Scholar]
36
37. Lopez-Vidriero E, Goulding KA, Simon DA, Sanchez M, Johnson DH. The use of platelet-rich plasma in arthroscopy and sports medicine: optimizing the healing environment. Arthroscopy. 2010; 26: 269–278. [PubMed] [Google Scholar]
37
38. Gassling VL, Açil Y, Springer IN, Hubert N, Wiltfang J. Platelet-rich plasma and platelet-rich fibrin in human cell culture. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009; 108: 48–55. [PubMed] [Google Scholar]
38
39. Kawase T, Okuda K, Wolff LF, Yoshie H. Platelet-rich plasma-derived fibrin clot formation stimulates collagen synthesis in periodontal ligament and osteoblastic cells in vitro. J Periodontol. 2003; 74: 858–864. [PubMed] [Google Scholar]
39
40. Kawase T, Okuda K, Saito Y, Yoshie H. In vitro evidence that the biological effects of platelet-rich plasma on periodontal ligament cells is not mediated solely by constituent transforming-growth factor-beta or platelet-derived growth factor. J Periodontol. 2005; 76: 760–767. [PubMed] [Google Scholar]
40
41. Dohan Ehrenfest DM, Doglioli P, de Peppo GM, Del Corso M, Charrier JB. Choukroun's platelet-rich fibrin (PRF) stimulates in vitro proliferation and differentiation of human oral bone mesenchymal stem cell in a dose-dependent way. Arch Oral Biol. 2010; 55: 185–194. [PubMed] [Google Scholar]
41
42. Tidball JG. Inflammatory cell response to acute muscle injury. Med Sci Sports Exerc. 1995; 27: 1022–1032. [PubMed] [Google Scholar]
42
43. Froum SJ, Wallace SS, Tarnow DP, Cho SC. Effect of platelet-rich plasma on bone growth and osseointegration in human maxillary sinus grafts: three bilateral case reports. Int J Periodontics Restorative Dent. 2002; 22: 45–53. [PubMed] [Google Scholar]
43
44. Gruber R, Varga F, Fischer MB, Watzek G. Platelets stimulate proliferation of bone cells: involvement of platelet-derived growth factor, microparticles and membranes. Clin Oral Implants Res. 2002; 13: 529–535. [PubMed] [Google Scholar]
44
45. Kawase T, Okuda K, Momose M, Kato Y, Yoshie H, Burns DM. Enamel matrix derivative (EMDOGAIN) rapidly stimulates phosphorylation of the MAP kinase family and nuclear accumulation of smad2 in both oral epithelial and fibroblastic human cells. J Periodontal Res. 2001; 36: 367–376. [PubMed] [Google Scholar]
45
46. Keila S, Nemcovsky CE, Moses O, Artzi Z, Weinreb M. In vitro effects of enamel matrix proteins on rat bone marrow cells and gingival fibroblasts. J Dent Res. 2004; 83: 134–138. [PubMed] [Google Scholar]
46
47. Sanders JE, Chuang A, Swiec GD, Bisch FC, Herold RW, Buxton TB, et al. The effects of enamel matrix derivative and cyclic mechanical strain on human gingival fibroblasts in an in vitro defect healing model. Int J Periodontics Restorative Dent. 2011; 31: 671–678. [PubMed] [Google Scholar]
47
ORIGINAL_ARTICLE
Evaluation of the Effect of a Topical Gel Form of Pistacia Atlantica and Trachyspermum Ammi on Induced Oral Mucositis in Male Golden Hamsters by Bio-Marker Indices and Stereological Assessment
Statement of the Problem: Oral mucositis (OM) is a common inflammatory complication consequent to chemotherapy or radiotherapy in cancer patients that affects their quality of life. Therefore, finding an effective treatment for OM is always imperative. Purpose:The purpose of this experimental study was to measure the stereological, anti-inflammatory and antioxidant markers of hydro-alcoholic extract of Pistacia Atlantica (P. atlantica) leaves, Trachyspermum Ammi (T. ammi) fruits and their mixture on induced OM in hamsters. Materials and Method: In Experimental study, OM was generated by the method employed by Tanideh et al., in 90 hamsters, by 5-FU (5-fluorouracil 65 mg/kg, IP). All the animals were divided into 5 groups: control, topical gel base, hydro-alcoholic extract 3% of P. atlantica, hydro-alcoholic extract 1% of T. ammi, and a mixture of the extracts of the two plants. On days 13, 15, and 17, the cheek pouch samples were harvested. Stereological scores and the levels of malondialdehyde (MDA), Superoxide dismutase (SOD), myeloperoxidase (MPO), and interleukin-1B (IL-1B) in the pouch tissue were measured. Results: Lower levels of MPO, MDA, and IL-1B and an increase of SOD level were discovered in the mixture-treated group in comparison with other groups. As an aspect of MDA, no significant differences were detected between the topical gel form of P. atlantica and T. ammi groups on days 13 (p = 0.648), 15 (p = 0.981) and 17 (p = 0.540). No variations of MPO were detected among P. atlantica and T. ammi groups on days 13 (p = 0.159) and 15 (p = 0.694); however, the MPO activity of the T. ammi group was significantly lower than the P. atlantica groupon day 17 (5.57±0.56 vs. 6.48±0.35 U/ml, p < .001). The volume density of the epithelium increased in the mixture- treated group (p < 0.05). Conclusion: The results of this study indicated that the mixture of P. atlantica leaves and T. Ammi fruits might be effective in the treatment of OM.
https://dentjods.sums.ac.ir/article_44918_7041cfde3c70cdd4f378a7fea7af3bc8.pdf
2019-12-01
240
248
10.30476/dentjods.2019.44918
● Oral Mucositis ● Animal Model ● Pistacia atlantica ● Trachyspermum Ammi ● Chemotherapy
Nader
Tanideh
tanidehn@gmail.com
1
Stem Cell Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
AUTHOR
Abbas Ali
Zareh
tanideh@sums.ac.ir
2
School of Dental, Shiraz University of Medical Sciences, Shiraz, Iran.
AUTHOR
Mohammad
Fani
ffrkhi@ymail.com
3
Dept. of Oral and Maxillofacial Medicine, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
AUTHOR
Maryam
Mardani
mardanim@sums.ac.ir
4
Dept. of Oral Medicine, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
AUTHOR
Farnaz
Farrokhi
dr.f.f.shiraz@gmail.com
5
Student Research Committee, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
LEAD_AUTHOR
Ali
Talati
ali.680089@gmail.com
6
Young Researchers and Elite Club, Shiraz Branch, Islamic Azad University, Shiraz, Iran.
AUTHOR
Omid
Koohi Hosseinabadi
7
Laboratory Animals Center, Shiraz University of Medical Sciences, Shiraz, Iran.
AUTHOR
Mahsa
Kamali
mhskamali@gmail.com
8
Stem Cell Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
AUTHOR
1. Tanideh N, Tavakoli P, Saghiri MA, Garcia-Godoy F, Amanat D, Tadbir AA, et al. Healing acceleration in hamsters of oral mucositis induced by 5-fluorouracil with topical Calendula officinalis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013; 115: 332–338. [PubMed] [Google Scholar]
1
2. Lee CS, Ryan EJ, Doherty GA. Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: the role of inflammation. World J Gastroenterol. 2014; 20: 3751–361. [PMC free article] [PubMed] [Google Scholar]
2
3. Halliwell B. The antioxidant paradox. Lancet. 2000; 355: 1179–1180. [PubMed] [Google Scholar]
3
4. Chatterjee S, Goswami N, Bhatnagar P. Estimation of Phenolic Components and in vitro Antioxidant Activity of Fennel (Foeniculum vulgare) and Ajwain (Trachyspermum ammi) seeds. Advances in Bioresearch. 2012; 3: 109–118. [Google Scholar]
4
5. Stone R, Fliedner MC, Smiet AC. Management of oral mucositis in patients with cancer. Eur J Oncol Nurs. 2005; 9 Suppl 1: S24–S32. [PubMed] [Google Scholar]
5
6. Thangam C, Dhananjayan R. Antiinflammatory potential of the seeds of Carum copticum Linn. Indian Journal of Pharmacology. 2003; 35: 388–391. [Google Scholar]
6
7. Hussein G, Miyashiro H, Nakamura N, Hattori M, Kakiuchi N, Shimotohno K. Inhibitory effects of sudanese medicinal plant extracts on hepatitis C virus (HCV) protease. Phytother Res. 2000; 14: 510–516. [PubMed] [Google Scholar]
7
8. Rasooli I, Fakoor MH, Yadegarinia D, Gachkar L, Allameh A, Rezaei MB. Antimycotoxigenic characteristics of Rosmarinus officinalis and Tra-chyspermum copticum L. essential oils. Int J Food Microbiol 2008; 122: 135–139. [PubMed] [Google Scholar]
8
9. Dashti-Rahmatabadi MH, Hejazian SH, Morshedi A, Rafati A. The analgesic effect of Carum copticum extract and morphine on phasic pain in mice. J Ethnopharmacol. 2007; 109: 226–228. [PubMed] [Google Scholar]
9
10. Bera D, Lahiri D, Nag A. Novel natural antioxidant for stabilization of edible oil: the ajowan (Carum copticum) extract case. Journal of the American Oil Chemists' Society. 2004; 81: 169–172. [Google Scholar]
10
11. Peksel A, Arisan‐Atac I, Yanardag R. Evaluation of antioxidant and antiacetylcholinesterase activities of the extracts of Pistacia atlantica Desf. Leaves. Journal of food biochemistry 2010; 34: 451–476. [Google Scholar]
11
12. Benhammou N, Bekkara FA, Panovska TK. Antioxidant and antimicrobial activities of the Pistacia lentiscus and Pistacia atlantica extracts. African Journal of Pharmacy and Pharmacology. 2008; 2:022–028. [Google Scholar]
12
13. Goswami N, Chatterjee S. Assessment of free radical scavenging potential and oxidative DNA dam-age preventiveactivity of Trachyspermum ammi L. (carom) and Foeniculum vulgare Mill. (fennel) seed extracts. Biomed Res Int. 2014; 2014: 582767. [PMC free article] [PubMed] [Google Scholar]
13
14. Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med. 1990; 9: 515–540. [PubMed] [Google Scholar]
14
15. Pulli B, Ali M, Forghani R, Schob S, Hsieh KL, Wojtkiewicz G, et al. Measuring myeloperoxidase activity in biological samples. PLoS One. 2013; 8: e67976. [PMC free article] [PubMed] [Google Scholar]
15
16. Ghalem BR. Bactericidal activity of Pistacia atlantica. Desf mastic gum against certain pathogens. Afr J Plant Sci. 2009; 3: 13–15. [Google Scholar]
16
17. Ghalem BR. Essential oil from gum of Pistacia atlantica Desf. Screening of antimicrobial activity. Afr J Pharm Pharacol. 2009; 3: 87–91. [Google Scholar]
17
18. Rhouma A BDH, Ghanmi S, Ben Salah H, Romdhane M, Demak M. Antimicrobial activities of leaf extracts of Pistacia and Schinus species against some ploant pathogenic fungi and bacteria. J Plant Pathol. 2009; 91: 339–345. [Google Scholar]
18
19. Singh I, Singh VP. Antifungal properties of aqueous and organic extracts of seed plants against Aspergillus flavus and A. niger. Phytomorphology. 2000; 20: 151–157. [Google Scholar]
19
20. Benhassaini H, Bendahmane M, Benchalgo N. The chemical composition of fruits of Pistacia atlantica desf. Subsp. Atlantica from Algeria. Chemistry of Natural Compounds. 2007;43:121, 124. [Google Scholar]
20
21. Rahimi R, Mozaffari S, Abdollahi M. On the use of herbal medicines in management of inflammatory bowel diseases: a systematic re-view of animal and human studies. Dig Dis Sci. 2009; 54: 471–480. [PubMed] [Google Scholar]
21
22. Yang SK, Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis. 2001; 7: 260–270. [PubMed] [Google Scholar]
22
23. Tanideh N, Davarmanesh M, Andisheh-Tadbir A, Ranjbar Z, Mehriar P, Koohi-Hosseinabadi O. Healing acceleration of oral mucositis induced by 5-fluorouracil with Pistacia atlantica (bene) essential oil in hamsters. J Oral Pathol Med. 2017; 46: 725–730. [PubMed] [Google Scholar]
23
24. Farhoosh R, Tavassoli-Kafrani MH, Sharif A. Antioxidant activity of the fractions separated from the unsaponifiable matter of bene hull oil. Food Chemistry. 2011; 126: 583–589. [Google Scholar]
24
25. El-Housseiny AA1 SS, El-Masry AA, Allam AA. The effectiveness of vitamin "E" in the treatment of oral mucositis in children receiving chemotherapy. J Clin Pediatr Dent. 2007; 31: 167–170. [PubMed] [Google Scholar]
25
26. Üçüncü H, Ertekin MV, Yörük Ö, Sezen O, Özkan A, Erdoğan F, et al. Vitamin E and L-carnitine, separately or in combination, in the prevention of radiation-induced oral mucositis and myelosuppression: a controlled study in a rat model. Journal of radiation research. 2006; 47: 91–102. [PubMed] [Google Scholar]
26
27. Wadleigh RG, Redman RS, Graham ML, Krasnow SH, Anderson A, Cohen MH. Vitamin E in the treatment of chemotherapy-induced mucositis. Am J Med. 1992; 92: 481–484. [PubMed] [Google Scholar]
27
28. Mutlu-Türkoğlu U, Erbil Y, Oztezcan S, Olgaç V, Toker G, Uysal M. The effect of selenium and/or vitamin E treatments on radiation-induced intestinal injury in rats. Life Sci. 2000; 66: 1905–1913. [PubMed] [Google Scholar]
28
29. Aftab K, Atta-Ur-Rahman Usmanghani K. pressure lowering action of active principle from Trachyspermum ammi (L.) sprague. Phytomedicine. 1995; 2: 35–40. [PubMed] [Google Scholar]
29
30. Khan R, Zakir M, Khanam Z, Shakil S, Khan AU. Novel compound from Trachyspermum ammi (Ajowan caraway) seeds with antibiofilmand antiadherence activities against Streptococcus mutans: a potential chemotherapeutic agent against dental caries. J Appl Microbiol. 2010; 109: 2151–2159. [PubMed] [Google Scholar]
30
31. Srivastava KC. Extract of a spice--omum (Trachyspermum ammi)-shows antiaggregatory effects and alters arachidonic acid metabolism in human platelets. Prostaglandins Leukot Essent Fatty Acids. 1988; 33: 1–6. [PubMed] [Google Scholar]
31
32. Velmurugan C, Geetha C, Shajahan S, Vijayakumar S, Kumar PL. Wound healing potential of leaves of eucalyptus citriodoralin rats. World J Pharm Sci. 2014;2:62–71. [Google Scholar]
32
33. Choudhary G. Wound healing activity of the ethanol extract of Terminalia bellirica Roxb. Fruits Nat Prod Rad. 2008; 7:19–21. [Google Scholar]
33
34. El Ghalbzouri A, Hensbergen P, Gibbs S, Kempenaar J, van der Schors R, Ponec M. Fibroblasts facilitate re-epithelialization in wounded human skin equivalents. Lab Invest. 2004; 84: 102–112. [PubMed] [Google Scholar]
34
ORIGINAL_ARTICLE
Expression of Paxillin in Benign and Malignant Salivary Gland Tumors
Statement of the Problem: Paxillin is a major cytoskeletal protein aberrantly deregulated in various human cancers and involved in tumor growth and invasion. However, the clinicopathological and prognostic significance of paxillin in salivary gland tumors (SGTs) is still unclear. Purpose: This study was conducted to evaluate the relationship between paxillin expression and clinicopathological features of patients with SGTs. Materials and Method: In this retrospective study, 50 paraffin-embedded tissue samples which were histologically confirmed as benign (pleomorphic adenoma, PA) or malignant (mucoepidermoid carcinoma (MEC), adenoid cystic carcinoma, ACC) SGTs, and 19 specimens from those with normal salivary gland (NSG) as a control group were assessed for paxillin expression using the immunohistochemistry. The paxillin expression in our samples was scored based on the extent and intensity of immunoreactivity and compared with histological type, clinical stage, and distant metastasis. Results: High paxillin expression was identified in 66% of SGTs whereas all patients with NSG showed low expression (p < 0.0001). Although the expression of paxillin in patients with benign and malignant tumors is similar, there is a significant difference between patients with PA, MEC, and ACC with that of the NSG (p < 0.0001). Paxillin expression was not correlated with clinicopathological features of patients Conclusion: High expression of paxillin was observed in tumoral tissues compared with the controls that establish an important role of paxillin in SGTs but its prognostic role was unclear and need further evaluation.
https://dentjods.sums.ac.ir/article_44909_9137209ed712b3427c01adc15387d8a3.pdf
2019-12-01
249
254
10.30476/dentjods.2019.44909
● Mucoepidermoid Carcinoma ● Paxillin ● Pleomorphic Adenoma ● Immunohistochemistry
Azadeh
AndisheTadbir
andisheh202003@yahoo.com
1
Oral and Dental Disease Research Center, Dept. of Oral and Maxillofacial Pathology, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
LEAD_AUTHOR
Aysuda
Afshari
2
Undergraduate Student, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
AUTHOR
Mohammad Javad
Ashraf
ashrafm@sums.ac.ir
3
Dept. of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
AUTHOR
. Melo GM, Cervantes O, Abrahao M, Covolan L, Ferreira ES, Baptista HA. A brief history of salivary gland surgery. Rev Col Bras Cir. 2017; 44: 403–412. [PubMed] [Google Scholar]
1
2. Randy Todd D. The Molecular Biology of Benign and Malignant Salivary Gland Tumors. Salivary Gland Pathology: Diagnosis and Management. 2nd ed . USA: Wiely ; 2015. pp. 203–232. [Google Scholar]
2
3. Wang X, Luo Y, Li M, Yan H, Sun M, Fan T. Management of salivary gland carcinomas - a review. Oncotarget. 2017; 8: 3946–3956. [PMC free article] [PubMed] [Google Scholar]
3
4. Peravali RK, Bhat HH, Upadya VH, Agarwal A, Naag S. Salivary gland tumors: a diagnostic dilemma! . J Maxillofac Oral Surg. 2015;( 14(Suppl 1)):438–442. [PMC free article] [PubMed] [Google Scholar]
4
5. Ettl T, Schwarz-Furlan S, Gosau M, Reichert TE. Salivary gland carcinomas. Oral Maxillofac Surg. 2012; 16: 267–283. [PubMed] [Google Scholar]
5
6. Chen DL, Wang ZQ, Ren C, Zeng ZL, Wang DS, Luo HY, et al. Abnormal expression of paxillin correlates with tumor progression and poor survival in patients with gastric cancer. J Transl Med. 2013; 11: 277. [PMC free article] [PubMed] [Google Scholar]
6
7. Xiao LJ, Zhao EH, Zhao S, Zheng X, Zheng HC, Takano Y, et al. Paxillin expression is closely linked to the pathogenesis, progression and prognosis of gastric carcinomas. Oncol Lett. 2014; 7: 189–194. [PMC free article] [PubMed] [Google Scholar]
7
8. Du C, Wang X, Zhang J, Liu X, Zhu J, Liu Y. Paxillin is positively correlated with the clinicopathological factors of colorectal cancer, and knockdown of Paxillin improves sensitivity to cetuximab in colorectal cancer cells. Oncol Rep. 2016; 35: 409–417. [PubMed] [Google Scholar]
8
9. Chen DL, Wang DS, Wu WJ, Zeng ZL, Luo HY, Qiu MZ, et al. Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer. Carcinogenesis. 2013; 34: 803–811. [PMC free article] [PubMed] [Google Scholar]
9
10. Wozniak MA, Modzelewska K, Kwong L, Keely PJ. Focal adhesion regulation of cell behavior. Biochim Biophys Acta. 2004; 1692: 103–119. [PubMed] [Google Scholar]
10
11. Wu DW, Chuang CY, Lin WL, Sung WW, Cheng YW, Lee H. Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting. Carcinogenesis. 2014; 35: 1823–1829. [PubMed] [Google Scholar]
11
12. Li BZ, Lei W, Zhang CY, Zhou F, Li N, Shi SS, et al. Increased expression of paxillin is found in human oesophageal squamous cell carcinoma: a tissue microarray study. J Int Med Res. 2008; 36: 273–278. [PubMed] [Google Scholar]
12
13. Jagadeeswaran R, Surawska H, Krishnaswamy S, Janamanchi V, Mackinnon AC, Seiwert TY, et al. Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion. Cancer Res. 2008; 68: 132–142. [PMC free article] [PubMed] [Google Scholar]
13
14. Wu DW, Cheng YW, Wang J, Chen CY, Lee H. Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting. Cancer Res. 2010; 70: 10392–10401. [PubMed] [Google Scholar]
14
15. Short SM, Yoder BJ, Tarr SM, Prescott NL, Laniauskas S, Coleman KA, et al. The expression of the cytoskeletal focal adhesion protein paxillin in breast cancercorrelates with HER2 overexpression and may help predict response to chemotherapy: a retrospective immunohistochemical study. Breast J. 2007; 13: 130–139. [PubMed] [Google Scholar]
15
16. McCormack SJ, Brazinski SE, Moore JL Jr, Werness BA, Goldstein DJ. Activation of the focal adhesion kinase signal transduction pathway in cervicalcarcinoma cell lines and human genital epithelial cells immortalized with humanpapillomavirus type 18. Oncogene. 1997; 15: 265–274. [PubMed] [Google Scholar]
16
17. Kasai M, Guerrero-Santoro J, Friedman R, Leman ES, Getzenberg RH, DeFranco DB. The Group 3 LIM domain protein paxillin potentiates androgen receptor transactivation in prostate cancer cell lines. Cancer Res. 2003; 63: 4927–4935. [PubMed] [Google Scholar]
17
18. Sen A, De Castro I, Defranco DB, Deng FM, Melamed J, Kapur P, et al. Paxillin mediates extranuclear and intranuclear signaling in prostate cancer proliferation. J Clin Invest. 2012; 122: 2469–2481. [PMC free article] [PubMed] [Google Scholar]
18
19. Yin H, Zhang Q, Wang X, Li T, Wan Y, Liu Y, et al. Role of paxillin in colorectal carcinoma and its relationship to clinicopathological features. Chin Med J (Engl) 2014; 127: 423–429. [PubMed] [Google Scholar]
19
20. Li L, Wang J, Gao L, Gong L. Expression of paxillin in laryngeal squamous cell carcinoma and its prognostic value. Int J Clin Exp Pathol. 2015; 8:9232–9239. [PMC free article] [PubMed] [Google Scholar]
20
21. Sun LH, Yang FQ, Zhang CB, Wu YP, Liang JS, Jin S, et al. Overexpression of Paxillin Correlates with Tumor Progression and Predicts PoorSurvival in Glioblastoma. CNS Neurosci Ther. 2017; 23: 69–75. [PMC free article] [PubMed] [Google Scholar]
21
22. Shi J, Wang S, Zhao E, Shi L, Xu X, Fang M. Paxillin expression levels are correlated with clinical stage and metastasis in salivaryadenoid cystic carcinoma. J Oral Pathol Med. 2010; 39: 548–551. [PubMed] [Google Scholar]
22
23. Turner CE. Paxillin and focal adhesion signalling. Nat Cell Biol. 2000; 2: E231–E236. [PubMed] [Google Scholar]
23
24. Metalli D, Lovat F, Tripodi F, Genua M, Xu SQ, Spinelli M, et al. The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillin. Am J Pathol. 2010; 176: 2997–3006. [PMC free article] [PubMed] [Google Scholar]
24
25. Cai HX, Yang LC, Song XH, Liu ZR, Chen YB, Dong GK. Expression of paxillin and FAK mRNA and the related clinical significance in esophagealcarcinoma. Mol Med Rep. 2012; 5: 469–472. [PubMed] [Google Scholar]
25
26. Li HG, Xie DR, Shen XM, Li HH, Zeng H, Zeng YJ. Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma. World J Gastroenterol. 2005; 11: 1445–1451. [PMC free article] [PubMed] [Google Scholar]
26
27. Taghavi N, Sargolzaei S, Mashhadiabbas F, Akbarzadeh A, Kardouni P. Salivary Gland Tumors: A 15- year Report from Iran. Turk Patoloji Derg. 2016; 32: 35–39. [PubMed] [Google Scholar]
27
28. Jaafari-Ashkavandi Z, Ashraf MJ, Moshaverinia M. Salivary gland tumors: a clinicopathologic study of 366 cases in southern Iran. Asian Pac J Cancer Prev. 2013; 14: 27–30. [PubMed] [Google Scholar]
28
29. Shahsavari F, Khaniki M, Farbod M. Prevalence of Salivary Glands Lesions in Iran: A 10-Year Retrospective Study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014; 119: e174. [Google Scholar]
29
30. Athanasopoulou A, Aroukatos P, Nakas D, Repanti M, Papadaki H, Bravou V. Decreased ezrin and paxillin expression in human urothelial bladder tumors correlate with tumor progression. Urol Oncol. 2013;31:836–42. [PubMed] [Google Scholar]
30
31. Zhao CJ, Du SK, Dang XB, Gong M. Expression of paxillin is correlated with clinical prognosis in colorectal cancer patients. Med Sci Monit. 2015; 21:1989–1995. [PMC free article] [PubMed] [Google Scholar]
31
32. Zheng QS, Chen SH, Wu YP, Chen HJ, Chen H, Wei Y, et al. Increased Paxillin expression in prostate cancer is associated with advancedpathological features, lymph node metastases and biochemical recurrence. J Cancer. 2018; 9: 959–967. [PMC free article] [PubMed] [Google Scholar]
32
ORIGINAL_ARTICLE
Comparative Analysis of the Histopathologic Features, β-Catenin, and Ki67 Expression between Fibromatosis and Fibrosarcoma
Statement of the Problem: The biologic behavior and histopathological features of fibromatosis are intermediate between those of fibroma and fibrosarcoma. Purpose: The aim of the present study was to determine useful histopathologic and immunohistochemical characteristics for the differentiation of these lesions. Materials and Method: In this cross-sectional descriptive study, 40 specimens comprising 20 fibrosarcoma and 20 fibromatosis biopsies were selected. The histopathologic characteristics of these lesions were identified and immunohistochemical staining for Ki67 and β-catenin markers was performed. Sections were examined by light microscopy and positively stained cells were counted. Results were analyzed by SPSS 20 using Chi-square test, Mann-whitney test, and t-test (p < 0.05). Results: Statistical significant differences were observed between fibromatosis and fibrosarcoma in terms of distribution frequency, mitotic rate, herringbone pattern, cellularity, overlapping of nuclei, mean Ki67 score, and atypia rate. The other features including age, gender, necrosis, clarity of nucleoli and mean β-catenin were not significantly different. Conclusion: The present findings suggest the mitotic figures, Ki67, herringbone pattern, cellularity, and atypia are useful to differentiate fibromatosis from fibrosarcoma.
https://dentjods.sums.ac.ir/article_44900_04b800dab2a38e4d13f3dded5f719ad1.pdf
2019-12-01
255
263
10.30476/dentjods.2019.44900
Fibrosarcoma ● Fibromatosis ● Histopathology ● β
catenin ● Ki
67
Parviz
Deyhimi
deihimy@dnt.mui.ac.ir
1
Dept. of Oral and Maxillofacial Pathology, Torabinejad Dental Research Center, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran.
LEAD_AUTHOR
Mahmoud Reza
Arefian
dr.mahmoudreza.arefian@gmail.com
2
Postgraduate Student Dept. of Oral and Maxillofacial Pathology, Dental Research Center, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran.
AUTHOR
Parvin
Mahzouni
mahzouni@med.mui.ac.ir
3
Dept. of Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
AUTHOR
1. Neville BW, Damm DD, Allen CM. Oral and Maxillofacial Pathology. 4th ed. Saint Louis: Elsevier; 2016. pp. 481–482, 516-517. [Google Scholar]
1
2. Sharon SW, Goldblum JR, editors . In: Enzinger& Weiss’s Soft tissue tumors. 5th ed. Philadelphia: Mosby Elsevier; 2008. pp. 227–228, 304. [Google Scholar]
2
3. Regezi JA, Sciubba JJ, Jordan RC. Oral pathology: clinical pathologic correlations. 7th ed. St Louis : Elsevier; 2017. pp. 169–171. [Google Scholar]
3
4. Rosai J, editor . In: Rosai and Ackerman's Surgical Pathology. 10th ed. Philadelphia: Mosby Elsevier; 2011. pp. 47, 65, 2116–2120. [Google Scholar]
4
5. Stout AP. Juvenile fibromatoses. Cancer. 1954; 7: 953–978. [PubMed] [Google Scholar]
5
6. Seper L, Hoppe P, Kruse-Lösler B, Büchter A, Joos U, Kleinheinz J. Aggressive fibromatosis in the jaw and facial region with bone involvement. A review. Mund Kiefer Gesichtschir. 2005; 9: 349–362. [PubMed] [Google Scholar]
6
7. Angiero F, Benedicenti S, Stefani M. Fibromatosis of the head and neck: morphological, immunohistochemical and clinical features. Anticancer Res. 2008; 28(3B): 1725–1732. [PubMed] [Google Scholar]
7
8. Lü D, Yue L, Li D, Zeng H, Yang H. Aggressive fibromatosis of the head and neck (A report of two cases and literature review) Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2012; 26: 107–109. [PubMed] [Google Scholar]
8
9. Liu Y, Guan GF, Jin CS, Yang JP. Aggressive fibromatosis of the larynx: case report and brief review. J Int Med Res. 2011; 39: 682–689. [PubMed] [Google Scholar]
9
10. Abikhzer G, Bouganim N, Finesilver A. Aggressive fibromatosis of the head and neck: case report and review of the literature. J Otolaryngol. 2005; 34: 289–294. [PubMed] [Google Scholar]
10
11. Owens CL, Sharma R, Ali SZ. Deep fibromatosis (desmoid tumor): cytopathologic characteristics, clinicoradiologic features, and immunohistochemical findings on fine needle aspiration. Cancer. 2007; 111: 166–172. [PubMed] [Google Scholar]
11
12. Seper L, Bürger H, Vormoor J, Joos U, Kleinheinz J. Agressive fibromatosis involving the mandible--case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005; 99: 30–38. [PubMed] [Google Scholar]
12
13. Ferenc T, Wroński JW, Kopczyński J, Kulig A, Sidor M, Stalińska L, et al. Analysis of APC, alpha-, beta-catenins, and N-cadherin protein expression in aggressive fibromatosis (desmoid tumor) Pathol Res Pract. 2009; 205: 311–324. [PubMed] [Google Scholar]
13
14. Bo N, Wang D, Wu B, Chen L, Ruixue Ma. Analysis of β-catenin expression and exon 3 mutations in pediatric sporadic aggressive fibromatosis. Pediatr Dev Pathol. 2012; 15: 173–178. [PubMed] [Google Scholar]
14
15. Lips DJ, Barker N, Clevers H, Hennipman A. The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors) Eur J Surg Oncol. 2009; 35: 3–10. [PubMed] [Google Scholar]
15
16. Folpe AL. Fibrosarcoma: a review and update. Histopathology. 2014;64:12–25. [PubMed] [Google Scholar]
16
17. Soares AB, Lins LH, Macedo AP, Pereira-Neto JS, Vargas PA. Fibrosarcoma originating in the mandible. Med Oral Patol Oral Cir Bucal. 2006; 11: E243–E246. [PubMed] [Google Scholar]
17
18. Wadhwan V, Chaudhary MS, Gawande M. Fibrosarcoma of the oral cavity. Indian J Dent Res. 2010; 21: 295–298. [PubMed] [Google Scholar]
18
19. Yuwanati MB, Tupkari JV. Fibrosarcoma of mandible: a case report. Case Rep Dent. 2011; 2011: 536086. [PMC free article] [PubMed] [Google Scholar]
19
20. Wong SL. Diagnosis and management of desmoid tumors and fibrosarcoma. J Surg Oncol. 2008; 97: 554–558. [PubMed] [Google Scholar]
20
21. Bahrami A, Folpe AL. Adult-type fibrosarcoma: A reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period. Am J Surg Pathol. 2010; 34: 1504–1513. [PubMed] [Google Scholar]
21
22. Ng TL, Gown AM, Barry TS, Cheang MC, Chan AK, Turbin DA, et al. Nuclear beta-catenin in mesenchymal tumors. Mod Pathol. 2005; 18: 68–74. [PubMed] [Google Scholar]
22
23. Flórez-Moreno GA, Henao-Ruiz M, Santa-Sáenz DM, Castañeda-Peláez DA, Tobón-Arroyave SI. Cytomorphometric and immunohistochemical comparison between central and peripheral giant cell lesions of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008; 105: 625–632. [PubMed] [Google Scholar]
23
24. Deyhimi P, Hashemzadeh Z. Study of the biologic behavior of odontogenic keratocyst and orthokeratinaized odontogenic cyst using TGF-alpha and P53 markers. Pathol Res Pract. 2014; 210: 201–204. [PubMed] [Google Scholar]
24
25. Gnepp DR. Diagnostic Surgical Pathology of the Head and Neck. 2th ed. Philadelphia : Saunders Elsevier; 2009. p. 460. [Google Scholar]
25
26. Lin XY, Wang L, Zhang Y, Dai SD, Wang EH. Variable Ki67 proliferative index in 65 cases of nodular fasciitis, compared with fibrosarcoma and fibromatosis. Diagn Pathol. 2013; 8: 50. [PMC free article] [PubMed] [Google Scholar]
26
27. Clarke LE. Fibrous and fibrohistiocytic neoplasms: an update. Dermatol Clin. 2012; 30: 643–656. [PubMed] [Google Scholar]
27
28. Amary MF, Pauwels P, Meulemans E, Roemen GM, Islam L, Idowu B, et al. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool. Am J Surg Pathol. 2007; 31: 1299–309. [PubMed] [Google Scholar]
28
29. Bhattacharya B, Dilworth HP, Iacobuzio-Donahue C, Ricci F, Weber K, Furlong MA, et al. Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Am J Surg Pathol. 2005; 29: 653–659. [PubMed] [Google Scholar]
29
ORIGINAL_ARTICLE
Comparison of Bromelain Enzyme, Sodium Hypochlorite, and Titanium Tetrafluoride on Shear Bond Strength of Restorative Composite to Dentin: An in vitro Study
Statement of the Problem: Sufficient bond strength of composite restoration leads to its durability and survival; therefore, preparation of dentin surface for higher bond strength is essential. Purpose: Our aim is to assess the deproteinizing effect of 3% bromelain enzyme and compare it to 4% titanium tetrafluoride (TiF4) and 5% sodium hypochlorite (NaOCl) regarding the shear bond strength (SBS) of composite resin to dentin. Materials and Method: In this experimental study, 40 intact extracted human maxillary premolars were selected, and the occlusal surfaces of the teeth were sectioned at a depth of 2 mm from dentinoenamel junction. The teeth were divided into 4 groups (n=10). In Group 1, the teeth were etched with 37% phosphoric acid gel. In Group 2, the teeth were etched and deproteinized with 5% NaOCl. In Group 3, the teeth were etched and deproteinized with 4% TiF4. In Group 4, the teeth were etched and deproteinized with 3% bromelain enzyme. In each specimen, composites with 3 mm diameter and 2 mm height were prepared and cured. The test specimens were then stored in distilled water at room temperature for 7 days before conducting the SBS test (MPa). By universal testing machine at a crosshead speed of 1 mm/min, the results were analyzed using one-way ANOVA and Tukey test. Results: One-way ANOVA test demonstrated that pretreatment of dentin with a bromelain enzyme, TiF4 solution, or NaOCl was not statistically different regarding SBS to dentin (p = 0.790). Conclusion: 3% bromelain enzyme can be as effective as TiF4 and NaOCl and phosphoric acid 37% in terms of the SBS of composite resin to dentin.
https://dentjods.sums.ac.ir/article_44990_9474dd883086d79427de02068ed02c77.pdf
2019-12-01
264
270
10.30476/dentjods.2019.44990
Sodium Hypochlorite ● Shear Bond Strength ● Bromelain ● ToF4 ● Composite
Farahnaz
Sharafddein
sharafedinf@yahoo.com
1
Dept. of Operative Dentistry, Biomaterials Research Center, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
AUTHOR
Niloofar
Haghbin
haghbin.niloofar@gmail.com
2
Undergraduate Student, School of Dentistry, Shiraz University of Medical sciences, Shiraz, Iran.
LEAD_AUTHOR
1. Neville BW, Damm DD, Allen CM. Oral and Maxillofacial Pathology. 4th ed. Saint Louis: Elsevier; 2016. pp. 481–482, 516-517. [Google Scholar]
1
2. Sharon SW, Goldblum JR, editors . In: Enzinger& Weiss’s Soft tissue tumors. 5th ed. Philadelphia: Mosby Elsevier; 2008. pp. 227–228, 304. [Google Scholar]
2
3. Regezi JA, Sciubba JJ, Jordan RC. Oral pathology: clinical pathologic correlations. 7th ed. St Louis : Elsevier; 2017. pp. 169–171. [Google Scholar]
3
4. Rosai J, editor . In: Rosai and Ackerman's Surgical Pathology. 10th ed. Philadelphia: Mosby Elsevier; 2011. pp. 47, 65, 2116–2120. [Google Scholar]
4
5. Stout AP. Juvenile fibromatoses. Cancer. 1954; 7: 953–978. [PubMed] [Google Scholar]
5
6. Seper L, Hoppe P, Kruse-Lösler B, Büchter A, Joos U, Kleinheinz J. Aggressive fibromatosis in the jaw and facial region with bone involvement. A review. Mund Kiefer Gesichtschir. 2005; 9: 349–362. [PubMed] [Google Scholar]
6
7. Angiero F, Benedicenti S, Stefani M. Fibromatosis of the head and neck: morphological, immunohistochemical and clinical features. Anticancer Res. 2008; 28(3B): 1725–1732. [PubMed] [Google Scholar]
7
8. Lü D, Yue L, Li D, Zeng H, Yang H. Aggressive fibromatosis of the head and neck (A report of two cases and literature review) Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2012; 26: 107–109. [PubMed] [Google Scholar]
8
9. Liu Y, Guan GF, Jin CS, Yang JP. Aggressive fibromatosis of the larynx: case report and brief review. J Int Med Res. 2011; 39: 682–689. [PubMed] [Google Scholar]
9
10. Abikhzer G, Bouganim N, Finesilver A. Aggressive fibromatosis of the head and neck: case report and review of the literature. J Otolaryngol. 2005; 34: 289–294. [PubMed] [Google Scholar]
10
11. Owens CL, Sharma R, Ali SZ. Deep fibromatosis (desmoid tumor): cytopathologic characteristics, clinicoradiologic features, and immunohistochemical findings on fine needle aspiration. Cancer. 2007; 111: 166–172. [PubMed] [Google Scholar]
11
12. Seper L, Bürger H, Vormoor J, Joos U, Kleinheinz J. Agressive fibromatosis involving the mandible--case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005; 99: 30–38. [PubMed] [Google Scholar]
12
13. Ferenc T, Wroński JW, Kopczyński J, Kulig A, Sidor M, Stalińska L, et al. Analysis of APC, alpha-, beta-catenins, and N-cadherin protein expression in aggressive fibromatosis (desmoid tumor) Pathol Res Pract. 2009; 205: 311–324. [PubMed] [Google Scholar]
13
14. Bo N, Wang D, Wu B, Chen L, Ruixue Ma. Analysis of β-catenin expression and exon 3 mutations in pediatric sporadic aggressive fibromatosis. Pediatr Dev Pathol. 2012; 15: 173–178. [PubMed] [Google Scholar]
14
15. Lips DJ, Barker N, Clevers H, Hennipman A. The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors) Eur J Surg Oncol. 2009; 35: 3–10. [PubMed] [Google Scholar]
15
16. Folpe AL. Fibrosarcoma: a review and update. Histopathology. 2014;64:12–25. [PubMed] [Google Scholar]
16
17. Soares AB, Lins LH, Macedo AP, Pereira-Neto JS, Vargas PA. Fibrosarcoma originating in the mandible. Med Oral Patol Oral Cir Bucal. 2006; 11: E243–E246. [PubMed] [Google Scholar]
17
18. Wadhwan V, Chaudhary MS, Gawande M. Fibrosarcoma of the oral cavity. Indian J Dent Res. 2010; 21: 295–298. [PubMed] [Google Scholar]
18
19. Yuwanati MB, Tupkari JV. Fibrosarcoma of mandible: a case report. Case Rep Dent. 2011; 2011: 536086. [PMC free article] [PubMed] [Google Scholar]
19
20. Wong SL. Diagnosis and management of desmoid tumors and fibrosarcoma. J Surg Oncol. 2008; 97: 554–558. [PubMed] [Google Scholar]
20
21. Bahrami A, Folpe AL. Adult-type fibrosarcoma: A reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period. Am J Surg Pathol. 2010; 34: 1504–1513. [PubMed] [Google Scholar]
21
22. Ng TL, Gown AM, Barry TS, Cheang MC, Chan AK, Turbin DA, et al. Nuclear beta-catenin in mesenchymal tumors. Mod Pathol. 2005; 18: 68–74. [PubMed] [Google Scholar]
22
23. Flórez-Moreno GA, Henao-Ruiz M, Santa-Sáenz DM, Castañeda-Peláez DA, Tobón-Arroyave SI. Cytomorphometric and immunohistochemical comparison between central and peripheral giant cell lesions of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008; 105: 625–632. [PubMed] [Google Scholar]
23
24. Deyhimi P, Hashemzadeh Z. Study of the biologic behavior of odontogenic keratocyst and orthokeratinaized odontogenic cyst using TGF-alpha and P53 markers. Pathol Res Pract. 2014; 210: 201–204. [PubMed] [Google Scholar]
24
25. Gnepp DR. Diagnostic Surgical Pathology of the Head and Neck. 2th ed. Philadelphia : Saunders Elsevier; 2009. p. 460. [Google Scholar]
25
26. Lin XY, Wang L, Zhang Y, Dai SD, Wang EH. Variable Ki67 proliferative index in 65 cases of nodular fasciitis, compared with fibrosarcoma and fibromatosis. Diagn Pathol. 2013; 8: 50. [PMC free article] [PubMed] [Google Scholar]
26
27. Clarke LE. Fibrous and fibrohistiocytic neoplasms: an update. Dermatol Clin. 2012; 30: 643–656. [PubMed] [Google Scholar]
27
28. Amary MF, Pauwels P, Meulemans E, Roemen GM, Islam L, Idowu B, et al. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool. Am J Surg Pathol. 2007; 31: 1299–309. [PubMed] [Google Scholar]
28
29. Bhattacharya B, Dilworth HP, Iacobuzio-Donahue C, Ricci F, Weber K, Furlong MA, et al. Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Am J Surg Pathol. 2005; 29: 653–659. [PubMed] [Google Scholar]
29
ORIGINAL_ARTICLE
The Effect of Finish Line Design on the Fracture Strength of Zirconia Copings
Statement of the Problem: One of the major concerns about all ceramic crowns is their fracture resistance. Purpose: The purpose of this in vitro study was to evaluate the effect of two marginal designs (shoulder 90°, shoulder 135°) on the fracture resistance of zirconia copings. Materials and Method: In this in vitro study, 20 brass dies were prepared using milling machine: 10 with 1mm width shoulder 90° marginal design and the other 10 with 1mm width shoulder 135° finish line design. Zirconia cores with 0.5mm thickness and 30μm cement space were fabricated on brass dies. The copings were cemented on the dies and fracture test was done using a universal testing machine. Data were analyzed using Mann-Whitney test. Results: The mean value of fracture resistance for shoulder 90° finish line design were 368.3±109.4 N and for shoulder 135° finish line design were 518.4±115.5 N. Data analysis revealed a statistically significant difference between groups (p < 0.05). Conclusion: The results of this study showed that the finish line design of zirconia copings influences their fracture resistance. A 135° shoulder finish line design can improve the fracture resistance of zirconia crowns.
https://dentjods.sums.ac.ir/article_45001_b30a510cf43cef288b88164cb115f068.pdf
2019-12-01
271
275
10.30476/dentjods.2019.77720.
Zirconia ● Preparation ● Fracture Strength ● CAD/CAM
Zahra
Hashemi Ardakani
hashemiz1896@yahoo.com
1
Dept. of Prosthodontics, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
AUTHOR
Sahar
Khorsandipour
khorsandipour_sahar@yahoo.com
2
Undergraduate Student of Dentistry, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
AUTHOR
Mina
Mohghegh
mohaghegh_mina@yahoo.com
3
Dept. of Prosthodontics, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
LEAD_AUTHOR
Seyed Ahmad
Ghoreishian
4
Dept. of Prosthodontics, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
AUTHOR
Amir Ali Reza
Khaledi
amiralireza_khaledi@yahoo.com
5
Dept. of Prosthodontics, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
AUTHOR
1. Ferracane JL. Using posterior composites appropriately. J Am Dent Assoc. 1992; 123: 53–58. [PubMed] [Google Scholar]
1
2. Etemadi S, Smales RJ. Survival of resin-bonded porcelain veneer crowns placed with and with-out metal reinforcement. J Dent. 2006; 34: 139–145. [PubMed] [Google Scholar]
2
3. McLaren EA, White SN. Survival of In-Ceram crowns in a private practice: a prospective clinical trial. J Prosthet Dent. 2000; 83: 216–222. [PubMed] [Google Scholar]
3
4. Webber B, McDonald A, Knowles J. An in vitro study of the compressive load at fracture of Procera AllCeram crowns with varying thickness of veneer porcelain. J Prosthet Dent. 2003; 89: 154–160. [PubMed] [Google Scholar]
4
5. Jalalian E, Atashkar B, Rostami R. The effect of preparation design on the fracture resistance of zirconiacrown copings (computer associated design/ computer associated machine, CAD/CAM system) J Dent (Tehran) 2011; 8: 123–129. [PMC free article] [PubMed] [Google Scholar]
5
6. Jalalian E, Aletaha NS. The effect of two marginal designs (chamfer and shoulder) on the fracture resistance of all ceramic restorations, Inceram: an in vitro study. J Prosthodont Res. 2011; 55: 121–125. [PubMed] [Google Scholar]
6
7. Ahmadzade A, Golmohammadi F. Comparison of fracture resistance in two marginal design in IPS Emax restorations. J Mash Dent Sch. 2015; 39: 109–116. [Google Scholar]
7
8. Cho L, Choi J, Yi YJ, Park CJ. Effect of finish line variants on marginal accuracy and fracture strength of ceramic optimized polymer/fiber-reinforced composite crowns. J Prosthet Dent. 2004; 91: 554–560. [PubMed] [Google Scholar]
8
9. Di*Iorio D, Murmura G, Orsini G, Scarano A, Caputi S. Effect of margin design on the fracture resistance of Procera all ceram cores: an in vitro study. J Contemp Dent Pract. 2008; 9: 1–8. [PubMed] [Google Scholar]
9
10. Sadan A, Blutz MB, Lang B. Clinical consideration for densly sintered alumina and zirconia restorations. Part1. International Journal of Periodontics and Restorative Dentistry. 2005; 25: 213–219. [PubMed] [Google Scholar]
10
11. Beuer F, Aggstaller H, Edelhoff D, Gernet W. Effect of preparation design on the fracture resistance of zirconiacrown copings. Dent Mater J. 2008; 27: 362–367. [PubMed] [Google Scholar]
11
12. Shinya A, Lassila LV, Vallittu PK. The effect of preparation design on the marginal stress of resin-bonded metal-free crowns: a finite element study. Int J Prosthodont. 2008; 21: 445–447. [PubMed] [Google Scholar]
12
13. Reich S, Petschelt A, Lohbauer U. The effect of finish line preparation and layer thickness on the failure loadand fractography of ZrO2 copings. J Prosthet Dent. 2008; 99: 369–376. [PubMed] [Google Scholar]
13
14. Jalali H, Sadighpour L, Miri A, Shamshiri AR. Comparison of Marginal Fit and Fracture Strength of a CAD/CAM Zirconia Crown with Two Preparation Designs. J Dent (Tehran) 2015; 12: 874–881. [PMC free article] [PubMed] [Google Scholar]
14
15. Monaco C, Rosentritt M, Llukacej A, Baldissara P, Scotti R. Margin-al Adaptation, Gap Width, and facture strength of teeth Restored with different all-ceramic Vs Metal Ceramic Crown Systems: An in Vitro Study. Eur J Prosthodont Restor Dent. 2016; 24: 130–137. [PubMed] [Google Scholar]
15
16. Shillinburg HT. Fundamentals of fixed prosthodontics. 4th ed. Quintessence: USA; 2012. p. 142. [Google Scholar]
16
17. Vojdani M, Safari A, Mohaghegh M, Pardis S, Mahdavi F. The effect of porcelain firing and type of finish line on the marginal fit of zirconia copings. J Dent (Shiraz) 2015; 16: 113–120. [PMC free article] [PubMed] [Google Scholar]
17
18. Fujimoto J, Land MF, Rosensteil SF. Contemporary fixed prosthodontics. 4th ed. Mosby Elsevier: USA; 2006. p. 324. [Google Scholar]
18
ORIGINAL_ARTICLE
Impact of One-Stage Full Mouth Disinfection and Periodontal Surgery on Oral Health-Related Quality of Life
Statement of the Problem: Information on patient-centered outcomes of periodontal disease and the impact of different periodontal treatment phases on the life quality of periodontal patients is limited. Purpose: This study sought to compare patients’ perception of their oral health-related quality of life (OHQoL) following one-stage full mouth disinfection (OSFMD) and surgical periodontal treatment. Materials and Method: A pre-and post-interventional study design was conducted in two phases on a single group of patients. Subjects were recruited from moderate to severe chronic periodontitis patients referred to a private clinic. At baseline and after each treatment phase, periodontal parameters were recorded by a blind examiner. Patients received OSFMD, followed by periodontal flap surgeries and completed the validated Iranian version of the OHIP-49 questionnaire (OHIP-35-IR) at three time points (baseline, two weeks post-initial therapy and after completion of surgical phase). Data were analyzed using repeated measure ANOVA, paired and independent t-tests, and multivariate regression analysis by SPSS software version 21. Results: 38 patients (14 men, 24 women, mean age 40.30±11.93) completed the study. Periodontal parameters showed progressive improvement from baseline to the end of the study (p < 0.05). The total mean OHIP-35-IR score at baseline (89.25±19.26) was significantly improved (reduced) compared to each treatment phase (75.63±17.15 and 74.22±15.46, respectively; p < 0.001), with no significant difference between treatments. Improvements in subdomains of psychological discomfort, functional limitation, physical pain, and handicap accounted for the changes. The effect size was calculated to be 0.80 for the first and 0.66 for the second treatment phases. Conclusion: Within limits, OSFMD and periodontal surgical treatment have positive impacts on the OHQoL of patients. Intensive periodontal non-surgical treatment is as effective as surgical intervention for achieving desirable patient-centered outcomes.
https://dentjods.sums.ac.ir/article_45002_181a3469c54b446f428dbafe25286ad7.pdf
2019-12-01
276
284
10.30476/dentjods.2019.77748.
Chronic periodontitis ● Quality of life ● Dental scaling ● Root planning ● Surgery ● Periodontal disease
therapy
Golpar
Radafshar
golishad@gmail.com
1
Dental Sciences Research Center, Dept. of Periodontology, Faculty of Dentistry, Guilan University of Medical Sciences, Rasht, Iran.
LEAD_AUTHOR
Marziyeh
Movahedi Amiri
ahooramovahedi@yahoo.com
2
Dental Sciences Research Center, Faculty of Dentistry, Guilan University of Medical Sciences, Rasht, Iran.
AUTHOR
1. Jiao J, Shi D, Cao ZQ, Meng HX, Lu RF, Zhang L, et al. Effectiveness of non-surgical periodontal therapy in a large Chinese population with chronic periodontitis. J Clin Periodontol. 2017; 44: 42–50. [PubMed] [Google Scholar]
1
2. Heitz-Mayfield LJ, Trombelli L, Heitz F, Needleman I, Moles D. A systematic review of the effect of surgical debridement vs non-surgicaldebridement for the treatment of chronic periodontitis. J Clin Periodontol. 2002; 29 Suppl 3: 92–102. [PubMed] [Google Scholar]
2
3. Drisko CL. Periodontal debridement: still the treatment of choice. J Evid Based Dent Pract. 2014; 14 Suppl: 33–41. [PubMed] [Google Scholar]
3
4. Shanbhag S, Dahiya M, Croucher R. The impact of periodontal therapy on oral health-related quality of lifein adults: a systematic review. J Clin Perio-dontol. 2012; 39: 725–735. [PubMed] [Google Scholar]
4
5. Brauchle F, Noack M, Reich E. Impact of periodontal disease and periodontal therapy on oral health-related quality of life. Int Dent J. 2013; 63: 306–311. [PubMed] [Google Scholar]
5
6. Ohrn K, Jönsson B. A comparison of two questionnaires measuring oral health-related quality of life before and after dental hygiene treatment in patients with periodontal disease. Int J Dent Hyg. 2012; 10: 9–14. [PubMed] [Google Scholar]
6
7. Wang TF, Fang CH, Hsiao KJ, Chou C. Effect of a comprehensive plan for periodontal disease care on oral health-related quality of life in patients with periodontal disease in Taiwan. Medicine (Baltimore) 2018;97:e9749. [PMC free article] [PubMed] [Google Scholar]
7
8. D'Avila GB, Carvalho LH, Feres-Filho EJ, Feres M, Leão A. Oral health impacts on daily living related to four different treatment protocols for chronic periodontitis. J Perio-dontol. 2005; 76: 1751–1757. [PubMed] [Google Scholar]
8
9. Durham J, Fraser HM, McCracken GI, Stone KM, John MT, Preshaw PM. Impact of periodontitis on oral health-related quality of life. J Dent. 2013; 41:370–376. [PubMed] [Google Scholar]
9
10. Lopez R, Baelum V. Spanish version of the Oral Health Impact Profile (OHIP-Sp) BMC Oral Health. 2006; 6: 11. [PMC free article] [PubMed] [Google Scholar]
10
11. Slade GD, Spencer AJ. Development and evaluation of the Oral Health Impact Profile. Community Dent Health. 1994; 11: 3–11. [PubMed] [Google Scholar]
11
12. Adulyanon S, Sheiham A. Oral impacts on daily performances. In: Slade G, editor. Measuring Oral Health and Quality of Life. Proceedings of the 4* Conference of the Californian Dental Association; 1996 Feb, 3. 1th ed. Los Angeles, USA, Chapel Hill: University of North Carolina; 1997. pp. 151–60. [Google Scholar]
12
13. Liu JY, Pow EH, Chen ZF, Zheng J, Zhang XC, Chen J. The Mandarin Chinese shortened version of Oral Health Impact Profile for partially edentate patients with implant-supported prostheses. J Oral Rehabil. 2012; 39:591–599. [PubMed] [Google Scholar]
13
14. Shaghaghian S, Taghva M, Abduo J, Bagheri R. Oral health-related quality of life of removable partial denture wearers and related factors. J Oral Rehabil. 2015; 42: 40–48. [PubMed] [Google Scholar]
14
15. Makino-Oi A, Ishii Y, Hoshino T, Okubo N, Sugito H, Hosaka Y, et al. Effect of periodontal surgery on oral health-related quality of life in patients who have completed initial periodon-tal therapy. J Periodontal Res. 2016; 51: 212–220. [PubMed] [Google Scholar]
15
16. Lindhe J, Ranney R, Lamster I, Charles A, Chung C-P, Fleming T, et al. Consensus report: Chronic periodontitis. Ann Periodontol. 1999; 4: 38. [Google Scholar]
16
17. Lenox JA, Kopczyk RA. A clinical system for scoring a patient's oral hygiene performance. J Am Dent Assoc. 1973; 86: 849–852. [PubMed] [Google Scholar]
17
18. Quirynen M, De Soete, M Boschmans, G Pauwels, M Coucke, W Teughels, W et. Benefit of "one-stage full-mouth disinfection" is explained by disinfection and root planing within 24 hours: a ran-domized controlled trial. J Clin Periodontol. 2006; 33:639–647. [PubMed] [Google Scholar]
18
19. Atchison KA, Gift HC. Perceived oral health in a diverse sample. Adv Dent Res. 1997; 11: 272–280. [PubMed] [Google Scholar]
19
20. Streiner DL, Norman GR. Validity. In: Streiner DL Editors. Health Measurement Scales. A Practical Guide to their Development and Use. 2th ed. New York: Oxford University Press; 1995. pp. 144–162. [Google Scholar]
20
21. Allen PF, McMillan AS, Locker D. An assessment of sensitivity to change of the Oral Health Impact Profile in a clinical trial. Community Dent Oral Epidemiol. 2001; 29: 175–182. [PubMed] [Google Scholar]
21
22. John MT, Feuerstahler L, Waller N, Baba K, Larsson P, Celebić A, et al. Confirmatory factor analysis of the Oral Health Impact Profile. J Oral Rehabil. 2014; 41: 644–652. [PMC free article] [PubMed] [Google Scholar]
22
23. Ozcelik O, Haytac MC, Seydaoglu G. Immediate post-operative effects of different periodontal treatment modalities on oral health-related quality of life: a randomized clinical trial. J Clin Periodontol. 2007; 34: 788–796. [PubMed] [Google Scholar]
23
24. Saito A, Hosaka Y, Kikuchi M, Akamatsu M, Fukaya C, Matsumoto S, et al. Effect of initial periodontal therapy on oral health-related quality of life in patients with periodontitis in Japan. J Periodontol. 2010; 81: 1001–1009. [PubMed] [Google Scholar]
24
25. Mendez M, Melchiors Angst, PD Stadler, AF Oppermann, RV Gomes. Impacts of supragingival and subgingival periodontal treatments on oralhealth-related quality of life. Int J Dent Hyg. 2017; 15: 135–141. [PubMed] [Google Scholar]
25
26. Saito A, Ota K, Hosaka Y, Akamatsu M, Hayakawa H, Fukaya C, et al. Potential impact of surgical periodontal therapy on oral health-relatedquality of life in patients with periodontitis: a pilot study. J Clin Periodontol. 2011; 38: 1115–1121. [PubMed] [Google Scholar]
26
27. Mailoa J, Lin GH, Khoshkam V, MacEachern M, Chan HL, Wang HL. Long-Term Effect of Four Surgical Periodontal Therapies and One Non-Surgical Therapy: A Systematic Review and Meta-Analysis. J Periodontol. 2015; 86: 1150–1158. [PubMed] [Google Scholar]
27
28. Wong RM, Ng SK, Corbet EF, Keung Leung W. Non-surgical periodontal therapy improves oral health-related quality of life. J Clin Periodontol. 2012; 39: 53–61. [PubMed] [Google Scholar]
28
29. Lindhe J, Westfelt E, Nyman S, Socransky SS, Haffajee AD. Long-term effect of surgical/non-surgical treatment of periodontal disease. J Clin Periodontol. 1984; 11: 448–458. [PubMed] [Google Scholar]
29
30. Kloostra PW, Eber RM, Wang HL, Inglehart MR. Surgical versus non-surgical periodontal treatment: psychosocial factorsand treatment outcomes. J Periodontol. 2006; 77: 1253–1260. [PubMed] [Google Scholar]
30
31. Chou YH, Yang YH, Kuo HC, Ho KY, Wang WC, Hu KF. Periodontal surgery improves oral health-related quality of life in chronic periodontitis patients in Asian popula-tion. Kaohsiung J Med Sci. 2017; 33: 523–529. [PubMed] [Google Scholar]
31
ORIGINAL_ARTICLE
In Vitro Comparison of Efficacy of Neolix and ProTaper Universal Retreatment Rotary Systems in Removal of Gutta-Percha Combined with Two Different Sealers
Statement of the Problem:The complete removal of filling material is an important step to regain access to the entire canal and facilitate the disinfection of the root canal system. Rotary nickel–titanium (NiTi) instruments systems have been proposed as an effective removal technique for root canal retreatment. Purpose: The aim of this study was to evaluate the efficacy of Neolix rotary system and ProTaper Universal retreatment system in the removal of gutta-percha combined with two different sealers. Materials and Method: In vivo study, eighty extracted human permanent mandibular premolarswere prepared using the ProTaper Universal rotary system to an apical size 30 (F3/0.06). The specimens were randomly divided into 4 groups (n=20) and subsequently filled with lateral condensation of gutta-percha and two sealers: AH-26 and Sure-Seal Root. The teeth were stored for 4 weeks at 37°C and 100% humidity and then retreated by one of the following rotary systems: Neolix or ProTaper Universal retreatment system. Teeth were then grooved and monitored under a stereomicroscope with 8× magnification. The images were transferred to the computer and the amount of filling material that remained on the root canal walls was scored using AutoCAD 2017 version 1.1software. Results were analyzed using one-way analysis of variance test and post hoc Tukey-HSD test (p < 0.05). Results:The mean percentage of remaining gutta-percha and sealer was significantly higher in apical third in all groups (p < 0.01). Post hoc Tukey test showed that there is significantly higher residual filling material in the group filled with gutta-percha and Sure-Seal Root sealer and retreated by Neoniti rotary system compared with other groups in both coronal and middle third of the canal. Conclusion: The Neoniti rotary system was as effective as ProTaper Universal retreatment system in retreatment of gutta-percha and AH-26 sealer but was significantly less effective in groups obturated with Sure-Seal Root sealer.
https://dentjods.sums.ac.ir/article_45006_b416c36bc7f6156775593bba9b1f2ef9.pdf
2019-12-01
285
291
10.30476/dentjods.2019.77825.
Retreatment ● AH26 ● Ni
Ti
Nooshin
Sadat Shojaee
shojaeen@sums.ac.ir
1
Dept. of Endodontics, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
LEAD_AUTHOR
Ehsan
Vakilinezhad
e.vakilinezhad@gmail.com
2
Undergraduate Student, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
AUTHOR
Mohammad Mehdi
Shokouhui
shekoohi_m@sums.ac.ir
3
Dept. of Endodontics, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
AUTHOR
1. Siqueira JF Jr, Rôças IN. Clinical implications and microbiology of bacterial persistence after treatment procedures. J Endod. 2008; 34: 1291–1301. [PubMed] [Google Scholar]
1
2. Torabinejad M, Corr R, Handysides R, Shabahang S. Outcomes of nonsurgical retreatment and endodontic surgery: a systematic review. J Endod. 2009; 35: 930–937. [PubMed] [Google Scholar]
2
3. Ruddle CJ. Nonsurgical retreatment. J Endod. 2004; 30: 827–845. [PubMed] [Google Scholar]
3
4. Wilcox LR, Krell KV, Madison S, Rittman B. Endodontic retreatment: evaluation of gutta-percha and sealer removal and canal reinstrumentation. J Endod. 1987; 13: 453–457. [PubMed] [Google Scholar]
4
5. Friedman S, Moshonov J, Trope M. Efficacy of removing glass ionomer cement, zinc oxide eugenol, and epoxy resin sealers from retreated root canals. Oral Surg Oral Med Oral Pathol. 1992; 73: 609–612. [PubMed] [Google Scholar]
5
6. Schirrmeister JF, Wrbas KT, Schneider FH, Altenburger MJ, Hellwig E. Effectiveness of a hand file and three nickel-titanium rotary instrumentsfor removing gutta-percha in curved root canals during retreatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 101: 542–547. [PubMed] [Google Scholar]
6
7. Friedman S, Stabholz A, Tamse A. Endodontic retreatment--case selection and technique. 3 . Retreatment techniques J Endod. 1990; 16: 543–549. [PubMed] [Google Scholar]
7
8. Friedman S, Mor C. The success of endodontic therapy--healing and functionality. J Calif Dent Assoc. 2004; 32: 493–503. [PubMed] [Google Scholar]
8
9. Krell KV, Neo J. The use of ultrasonic endodontic instrumentation in the re-treatment of a paste-filled endodontic tooth. Oral Surg Oral Med Oral Pathol. 1985; 60: 100–102. [PubMed] [Google Scholar]
9
10. Jeng HW, ElDeeb ME. Removal of hard paste fillings from the root canal by ultrasonicinstrumentation. J Endod. 1987; 13: 295–298. [PubMed] [Google Scholar]
10
11. Wilcox LR. Endodontic retreatment: ultrasonics and chloroform as the final step in reinstrumentation. J Endod. 1989; 15: 125–128. [PubMed] [Google Scholar]
11
12. Masiero AV, Barletta FB. Effectiveness of different techniques for removing gutta-percha during retreatment. Int Endod J. 2005; 38: 2–7. [PubMed] [Google Scholar]
12
13. Ring J, Murray PE, Namerow KN, Moldauer BI, Garcia-Godoy F. Removing root canal obturation materials: a comparison of rotary filesystems and re-treatment agents. J Am Dent Assoc. 2009; 140: 680–688. [PubMed] [Google Scholar]
13
14. Gergi R, Sabbagh C. Effectiveness of two nickel-titanium rotary instruments and a hand file for removing gutta-percha in severely curved root canals during retreatment: an ex vivo study. Int Endod J. 2007; 40: 532–537. [PubMed] [Google Scholar]
14
15. Hülsmann M, Bluhm V. Efficacy, cleaning ability and safety of different rotary NiTi instruments in root canal retreatment. Int Endod J. 2004; 37: 468–476. [PubMed] [Google Scholar]
15
16. Schirrmeister JF, Wrbas KT, Meyer KM, Altenburger MJ, Hellwig E. Efficacy of different rotary instruments for gutta-percha removal in root canal retreatment. J Endod. 2006; 32: 469–472. [PubMed] [Google Scholar]
16
17. Betti LV, Bramante CM. Quantec SC rotary instruments versus hand files for gutta-percharemoval in root canal retreatment. Int Endod J. 2001; 34: 514–519. [PubMed] [Google Scholar]
17
18. Imura N, Kato AS, Hata GI, Uemura M, Toda T, Weine F. A comparison of the relative efficacies of four hand and rotaryinstrumentation techniques during endodontic retreatment. Int Endod J. 2000; 33: 361–366. [PubMed] [Google Scholar]
18
19. Ferreira JJ, Rhodes JS, Ford TR. The efficacy of gutta-percha removal using ProFiles. Int Endod J. 2001; 34: 267–274. [PubMed] [Google Scholar]
19
20. Belli S, Ozcan E, Derinbay O, Eldeniz AU. A comparative evaluation of sealing ability of a new, self-etching, dual-curable sealer: hybrid root SEAL (MetaSEAL) Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008; 106: e45–e52. [PubMed] [Google Scholar]
20
21. Sure-endo corp. Sure-Seal Root, bioceramic sealing material. Available at: [http://www.suredent.com/en/seal /01.htm. ] [Google Scholar]
21
22. Lee KW, Williams MC, Camps JJ, Pashley DH. Adhesion of endodontic sealers to dentin and gutta-percha. J Endod. 2002; 28: 684–688. [PubMed] [Google Scholar]
22
23. Bürklein S, Hinschitza K, Dammaschke T, Schäfer E. Shaping ability and cleaning effectiveness of two single-file systems in severely curved root canals of extracted teeth: Reciproc and WaveOne versus Mtwo and Protaper. Int Endod J. 2012; 45: 449–461. [PubMed] [Google Scholar]
23
24. Pirani C, Ruggeri O, Cirulli PP, Pelliccioni GA, Gandolfi MG, Prati C. Metallurgical analysis and fatigue resistance of WaveOne and Protaper nickel-titanium instruments. Odontology. 2014; 102: 211–216. [PubMed] [Google Scholar]
24
25. Capar ID, Ertas H, Ok E, Arslan H, Ertas ET. Comparative study of different novel nickel-titanium rotary systems for root canal preparation in severely curved root canals. Journal of Endodontics. 2014; 40: 852–856. [PubMed] [Google Scholar]
25
26. Hiranus S, Pimkhaokham S, Sawasdichai J, Ebihara A, Suda H. Shaping ability of Protaper NEXT, Protaper Universal and iRace files in simulated S-shaped canals. Aust Endod J. 2016; 42: 32–36. [PubMed] [Google Scholar]
26
27. Aminsobhani M, Meraji N, Sadri E. Comparison of Cyclic Fatigue Resistance of Five Nickel Titanium Rotary File Systems with Different Manufacturing Techniques. J Dent (Tehran) 2015; 12:636–646. [PMC free article] [PubMed] [Google Scholar]
27
28. Moazzami F, Khojastepour L, Nabavizadeh M, Seied Habashi M. Cone-Beam Computed Tomography Assessment of Root CanalTransportation by Neoniti and Reciproc Single-File Systems. Iran Endod J. 2016; 11: 96–100. [PMC free article] [PubMed] [Google Scholar]
28
29. Rios Mde A, Villela AM, Cunha RS, Velasco RC, De Martin AS, Kato AS, et al. Efficacy of 2 reciprocating systems compared with a rotary retreatmentsystem for gutta-percha removal. J Endod. 2014; 40: 543–546. [PubMed] [Google Scholar]
29
30. Zuolo AS, Mello JE Jr, Cunha RS, Zuolo ML, Bueno CE. Efficacy of reciprocating and rotary techniques for removing filling material during root canal retreatment. Int Endod J. 2013; 46: 947–953. [PubMed] [Google Scholar]
30
31. Khoshbin E, Donyavi Z, Abbasi Atibeh E, Roshanaei G, Amani F. The Effect of Canal Preparation with Four Different Rotary Systems on Formation of Dentinal Cracks: An In Vitro Evaluation. Iran Endod J. 2018; 13: 163–168. [PMC free article] [PubMed] [Google Scholar]
31
32. Schirrmeister JF, Liebenow AL, Braun G, Wittmer A, Hellwig E, Al-Ahmad A. Detection and eradication of microorganisms in root-filled teethassociated with periradicular lesions: an in vivo study. J Endod. 2007; 33: 536–540. [PubMed] [Google Scholar]
32
33. Stabholz A, Friedman S. Endodontic retreatment--case selection and technique. Part 2: Treatmentplanning for retreatment. J Endod. 1988; 14: 607–614. [PubMed] [Google Scholar]
33
34. Rios Mde A, Villela AM, Cunha RS, Velasco RC, De Martin AS, Kato AS, et al. Efficacy of 2 reciprocating systems compared with a rotary retreatmentsystem for gutta-percha removal. J Endod. 2014; 40: 543–546. [PubMed] [Google Scholar]
34
35. Takahashi CM, Cunha RS, de Martin AS, Fontana CE, Silveira CF, da Silveira Bueno CE. In vitro evaluation of the effectiveness of Protaper universal rotaryretreatment system for gutta-percha removal with or without a solvent. J Endod. 2009; 35: 1580–1583. [PubMed] [Google Scholar]
35
36. Sae-Lim V, Rajamanickam I, Lim BK, Lee HL. Effectiveness of ProFile .04 taper rotary instruments in endodonticretreatment. J Endod. 2000; 26: 100–104. [PubMed] [Google Scholar]
36
37. Kosti E, Lambrianidis T, Economides N, Neofitou C. Ex vivo study of the efficacy of H-files and rotary Ni-Ti instruments to remove gutta-percha and four types of sealer. Int Endod J. 2006; 39: 48–54. [PubMed] [Google Scholar]
37
38. De Carvalho Maciel AC, Zaccaro Scelza MF. Efficacy of automated versus hand instrumentation during root canalretreatment: an ex vivo study. Int Endod J. 2006; 39: 779–784. [PubMed] [Google Scholar]
38
39. Uzunoglu E, Yilmaz Z, Sungur DD, Altundasar E. Retreatability of root canals obturated using gutta-percha with bioceramic, MTA and resin-based sealers. Iran Endod J. 2015; 10: 93–98. [PMC free article] [PubMed] [Google Scholar]
39
40. Teplitsky PE, Rayner D, Chin I, Markowsky R. Gutta percha removal utilizing GPX instrumentation. J Can Dent Assoc. 1992; 58: 53–58. [PubMed] [Google Scholar]
40
41. Ersev H, Yilmaz B, Dinçol ME, Dağlaroğlu R. The efficacy of ProTaper Universal rotary retreatment instrumentation to remove single gutta-percha cones cemented with several endodontic sealers. Int Endod J. 2012; 45: 756–762. [PubMed] [Google Scholar]
41
42. Só MV, Saran C, Magro ML, Vier-Pelisser FV, Munhoz M. Efficacy of ProTaper retreatment system in root canals filled with gutta-percha and two endodontic sealers. J Endod. 2008; 34: 1223–1225. [PubMed] [Google Scholar]
42
43. Nagas E, Cehreli Z, Uyanik MO, Durmaz V. Bond strength of a calcium silicate-based sealer tested in bulk or with different main core materials. Braz Oral Res. 2014; 28: 1–7. [PubMed] [Google Scholar]
43
44. Khoshbin E, Shokri A, Donyavi Z, Shahriari S, Salehimehr G, Farhadian M, et al. Comparison of the root canal debridement ability of two single filesystems with a conventional multiple rotary system in long oval-shapedroot canals: In vitro study. J Clin Exp Dent. 2017; 9: e939–e944. [PMC free article] [PubMed] [Google Scholar]
44
45. Fatima K, Nair R, Khasnis S, Vallabhaneni S, Patil JD. Efficacy of rotary and reciprocating single-file systems on differentaccess outlines for gutta-percha removal in retreatment: An in vitro study. J Conserv Dent. 2018; 21: 354–358. [PMC free article] [PubMed] [Google Scholar]
45
ORIGINAL_ARTICLE
Efficacy of Custom-Made Appliance by the Method of CAD/CAM Compared with Conventional Dressing for Reducing Facial Swelling after Maxillofacial Surgery
Statement of the Problem: Swelling of the surrounding tissue of surgical site is one of the most common, devastating effects after maxillofacial surgery and can have an effect on quality of life and the patients' satisfaction. Purpose: The purpose of this study was to investigate the effect of a custom-made appliance by the method of Computer-aided design/Computer-aided manufacturing (CAD/CAM) compared with conventional dressing for reducing facial swelling after maxillofacial surgery. Materials and Method: This clinical trial accomplished in 14 patients voluntarily referred to the Department of Oral and Maxillofacial Surgery at Bahonar hospital in Kerman. These patients were the candidate for surgical treatment of similar bilateral facial fractures (10 patients) and orthognathic surgery (4 patients). Facial computed tomography (CT) scans of the patients were taken to build up a custom-made appliance. Based on three-dimensional reconstruction from facial CT scan data, custom-made appliance was designed and built. Swelling on one side with custom-made appliance and on the opposite side with conventional dressing measured with paper tape graded before surgery, immediately after surgery, 24 hours, 48 hours, and 7 days later, we divided the patients into two groups of trauma and orthognathic surgical procedures Results: Based on the defined landmarks, all of the measurements were performed on both sides. Statistical analyses do not show any asymmetry before surgery (p = 0.48). In addition, there was no significant difference between two methods of dressing on the day of surgery and a day later (p = 0.084, p = 0.09), but there was a significant difference between two methods of dressing on second and seventh days. The swelling has decreased faster and further in our new method. Conclusion: Regarding the exact adaptation to the surgical site on facial skin, using custom-made appliance by the method of CAD/CAM could be an effective tool that reduces swelling after maxillofacial surgery.
https://dentjods.sums.ac.ir/article_45003_0bb141a6f2268e9874aa52ee0d194ff9.pdf
2019-12-01
292
297
10.30476/dentjods.2019.77797.
Face ● Truma ● Orthognathic surgery ● Custom
Javad
Faryabi
jfomfs@gmail.com
1
Dept. of Oral and Maxillofacial Surgery, Faculty of Dentistry, Member of Oral and Dental Diseases Research Center, Kerman University of Medical Sciences, Kerman, Iran.
LEAD_AUTHOR
Mohsen
Barzegar
2
Dept. of Oral and Maxillofacial Surgery, Faculty of Dentistry, Yazd Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
AUTHOR
Shiva
Pouradeli
3
Epidemiologist, Oral and Dental Disease Research Center and Kerman Social Determinants on Oral Health Research Center, Kerman University of Medical Sciences, Kerman, Iran.
AUTHOR
1. Szolnoky G, Szendi-Horváth K, Seres L, Boda K, Kemény L. Manual lymph drainage efficiently reduces postoperative facial swellingand discomfort after removal of impacted third molars. Lymphology. 2007; 40: 138–142. [PubMed] [Google Scholar]
1
2. Rana M, Gellrich NC, Joos U, Piffkó J, Kater W. 3D evaluation of postoperative swelling using two different coolingmethods following orthognathic surgery: a randomised observer blind prospective pilot study. Int J Oral Maxillofac Surg. 2011; 40: 690–696. [PubMed] [Google Scholar]
2
3. Rana M, Gellrich NC, von See C, Weiskopf C, Gerressen M, Ghassemi A, et al. 3D evaluation of postoperative swelling in treatment of bilateralmandibular fractures using 2 different cooling therapy methods: a randomized observer blind prospective study. J Craniomaxillofac Surg. 2013; 41: e17–e23. [PubMed] [Google Scholar]
3
4. Thaer AL, Salwan YH, Jamal AM. The influence of prophylactic dexamethasone on postoperative swelling and trismus following impacted mandibular third molar surgical extraction. J Bagh Colls Dentistry. 2010; 22: 85–90. [Google Scholar]
4
5. Villafuerte-Nuñez AE, Téllez-Anguiano AC, Hernández-Díaz O. Facial Edema Evaluation Using Digital Image Processing. Discrete Dynamics in Nature and Society. Available at: [https://www.hindawi.com/journals/ddns/ 2013/927843/ . ]
5
6. Hirai M, Niimi K, Iwata H, Sugimoto I, Ishibashi H, Ota T, Nakamura H. A comparison of interface pressure and stiffness between elastic stockings and bandages. Phlebology. 2009; 24: 120–124. [PubMed] [Google Scholar]
6
7. Feng Z, Dong Y, Zhao Y, Bai S, Zhou B, Bi Y, Wu G. Computer-assisted technique for the design and manufacture of realistic facial prostheses. Br J Oral Maxillofac Surg. 2010; 48: 105–109. [PubMed] [Google Scholar]
7
8. de Santana-Santos T, de Souza-Santos A, Martins-Filho PR, da Silva LC, de Oliveira E Silva ED, Gomes AC. Prediction of postoperative facial swelling, pain and trismus followingthird molar surgery based on preoperative variables. Med Oral Patol Oral Cir Bucal. 2013; 18: e65–e70. [PMC free article] [PubMed] [Google Scholar]
8
9. Gasperini G, Rodrigues de Siqueira IC, Rezende Costa L. Does low-level laser therapy decrease swelling and pain resulting from orthognathic surgery? . Int J Oral Maxillofac Surg. 2014;43:868–873. [PubMed] [Google Scholar]
9
10. Ristow O, Hohlweg-Majert B, Kehl V, Koerdt S, Hahnefeld L, Pautke C. Does elastic therapeutic tape reduce postoperative swelling, pain, and trismus after open reduction and internal fixation of mandibular fractures? . J Oral Maxillofac Surg. 2013; 71: 1387–1396. [PubMed] [Google Scholar]
10
11. Lietz-Kijak D, Kijak E, Krajczy M, Bogacz K, Łuniewski J, Szczegielniak J. The Impact of the Use of Kinesio Taping Method on the Reduction of Swelling in Patients After Orthognathic Surgery: A Pilot Study. Med Sci Monit . 2018;24:3736–3743. [PMC free article] [PubMed] [Google Scholar]
11
12. Modabber A, Madiha R, Ghassemi A, Marcus G, Nils-Claudius G, Frank H, Majeed R. Three-dimensional evaluation of postoperative swelling in treatment of zygomatic bone fractures using two different cooling therapy methods: a randomized, observer-blind, prospective study. Trials . 2013;14:238. [PMC free article] [PubMed] [Google Scholar]
12
13. Barbosa-Rebellato NL, Thomé AC, Costa-Maciel C, Oliveira J, Scariot R. Factors associated with complications of removal of third molars: a transversal study. Med Oral Patol Oral Cir Bucal. 2011; 16: e376–e380. [PubMed] [Google Scholar]
13
14. Akadiri OA, Obiechina AE. Assessment of difficulty in third molar surgery--a systematic review. J Oral Maxillofac Surg. 2009; 67: 771–774. [PubMed] [Google Scholar]
14
15. Gbotolorun OM, Arotiba GT, Ladeinde AL. Assessment of factors associated with surgical difficulty in impactedmandibular third molar extraction. J Oral Maxillofac Surg . 2007;65 :1977 –1983. [PubMed] [Google Scholar]
15
ORIGINAL_ARTICLE
Goldenhar Syndrome in a 6-Year-Old Patient: a Case Report and Review of Literature
Goldenhar syndrome (GHS) is a complex syndrome characterized by relation of mandibular hypoplasia, abnormality of the ear, ocular dermoid and vertebral disorders and hemi facial macrosomia. Treatment protocol depends on the patient’s age and systemic clinical presentations, with a multidisciplinary method often being required.This case report describes a typical 6-year-old female patient who presented to the Department of Pediatric Dentistry, Faculty of Dentistry, University of Medical Sciences, Kerman, Iran with mandibular hypoplasia, facial asymmetry, ear tags and ocular dermoid after plastic surgery. Diagnosis was based on clinical aspects, radiology and laboratory findings. GHS is a developmental complaint that can disturb many aspects of the patient's life; therefore, immediate treatment from birth is necessary.
https://dentjods.sums.ac.ir/article_44905_961305204a983cd5cd5a31bbf688b1aa.pdf
2019-12-01
298
303
10.30476/dentjods.2019.44905
Craniofacial Abnormalities ● Ventricular Septal Defects ● Mandibular Condyle ● Oral Manifestations ● Goldenhar Syndrome
Fatemeh
Jahanimoghadam
fatemehjahani4@gmail.com
1
Oral and Dental Diseases Research Center AND Kerman Social Determinants on Oral Health Research Center and Dept. of Pediatric Dentistry, School of Dentistry, Kerman University of Medical Sciences, Kerman, Iran.
LEAD_AUTHOR
Maryam
Sharifi
maryam2247@gmail.com
2
Resident Dept. of Pediatric Dentistry, School of Dentistry, Kerman University of Medical Sciences, Kerman, Iran.
AUTHOR
1. Harris T, Bashith MA, Shanbhag MM, Faheem M. Goldenhar syndrome: a rare entity. International Journal of Contemporary Pediatrics. 2017; 4: 1897–1899. [Google Scholar]
1
2. Patil NA, Patil AB. Goldenhar syndrome: Case report. IJSS Journal of Surgery. 2015; 1: 18–20. [Google Scholar]
2
3. Derbent M, Orün UA, Varan B, Mercan S, Yilmaz Z, Sahin FI, et al. A new syndrome within the oculo-auriculo-vertebral spectrum: microtia, atresia of the external auditory canal, vertebral anomaly, and complexcardiac defects. Clin Dysmorphol. 2005; 14: 27–30. [PubMed] [Google Scholar]
3
4. Al Kaissi A, Ben Chehida F, Ganger R, Klaushofer K, Grill F. Distinctive spine abnormalities in patients with Goldenhar syndrome: tomographic assessment. Eur Spine J. 2015; 24: 594–599. [PubMed] [Google Scholar]
4
5. Román Corona-Rivera J, López-Marure E, Gómez-Ruíz L, del Carmen Abreu-Fernández M, Quezada-López C, Pérez-Molina J, Santibañez-Escobar LP. Airway anomalies in the oculoauriculofrontonasal syndrome. Clin Dysmorphol. 2007; 16: 43–45. [PubMed] [Google Scholar]
5
6. Al-Droos M, Almomani B, Aljaouni M. Ocular Manifestations of Marfan syndrome In Seven Members of One Family from Libya. Middle East Journal of Age & Ageing. 2013; 10: 2. [Google Scholar]
6
7. Gorlin RJ, Cohen Jr MM, Hennekam RC. Syndromes of the head and neck. 4th ed. Oxford University Press : Oxford; 2001. pp. 1–1283. [Google Scholar]
7
8. Kokavec R. Goldenhar syndrome with various clinical manifestations. Cleft Palate Craniofac J. 2006; 43: 628–634. [PubMed] [Google Scholar]
8
9. Tuna EB, Orino D, Ogawa K, Yildirim M, Seymen F, Gencay K, et al. Craniofacial and dental characteristics of Goldenhar syndrome: a report of two cases. J Oral Sci. 2011; 53: 121–124. [PubMed] [Google Scholar]
9
10. Lisbôa RC, Mendez HM, Paskulin GA. Síndrome de Goldenhar e variantes: relato de sete pacientes. Rev AM RIGS. 1987; 31: 265–269. [Google Scholar]
10
11. Bustamante LNP, Guerra IVd, Iwahashi ER, Ebaid M. Síndrome de Goldenhar: relato de cinco casos em associaçäo com malformaçöes cardíacas. Arq Bras Cardiol. 1989; 53: 287–290. [PubMed] [Google Scholar]
11
12. Ferreira JM, Gonzaga J. Goldenhar syndrome. Rev Bras Oftalmol. 2016; 75: 401–404. [Google Scholar]
12
13. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16: 1215. [PMC free article] [PubMed] [Google Scholar]
13
14. Kulkarni V, Shah MD, Parikh A. Goldenhar syndrome (a case report) J Postgrad Med. 1985; 31: 177–179. [PubMed] [Google Scholar]
14
15. Bhuyan R, Pati AR, Bhuyan SK, Nayak BB. Goldenhar Syndrome: A rare case report. J Oral Maxillofac Pathol. 2016; 20: 328. [PMC free article] [PubMed] [Google Scholar]
15
16. Larsen W. Development of the eyes. Human embryology. 2nd ed. New York: Churchill Livingstone; 1993. pp. 1–479. [Google Scholar]
16
17. Tasse C, Majewski F, Böhringer S, Fischer S, Lüdecke HJ, Gillessen-Kaesbach G, et al. A family with autosomal dominant oculo-auriculo-vertebral spectrum. Clin Dysmorphol. 2007; 16: 1–7. [PubMed] [Google Scholar]
17
18. Bekibele CO, Ademola SA, Amanor-Boadu SD, Akang EE, Ojemakinde KO. Goldenhar syndrome: a case report and literature review. West Afr J Med. 2005; 24: 77–80. [PubMed] [Google Scholar]
18
19. Baum JL, Feingold M. Ocular aspects of Goldenhar's syndrome. Am J Ophthalmol. 1973; 75: 250–257. [PubMed] [Google Scholar]
19
20. De Golovine S, Wu S, Hunter JV, Shearer WT. Goldenhar syndrome: a cause of secondary immunodeficiency? . Allergy Asthma Clin Immunol. 2012;8:10. [PMC free article] [PubMed] [Google Scholar]
20
21. Hartsfield JK. Review of the etiologic heterogeneity of the oculo-auriculo-vertebral spectrum (Hemifacial Microsomia) Orthod Craniofac Res. 2007; 10: 121–128. [PubMed] [Google Scholar]
21
22. Chen H. Atlas of genetic diagnosis and counseling. Humana press. 10 th ed. Humana Press Inc: Totowa New Jersey; 2006. pp. 1–1075. [Google Scholar]
22
23. Limwongse C. Developmental Syndromes and Malformations of the Urinary Tract. Available at: [https://link. springer.com/referenceworkentry/10.1007/978-3-662-43596-0_5 . ]
23
24. Friedman S, Saraclar M. The high frequency of congenital heart disease in oculo-auriculo-vertebral dysplasia (Goldenhar's syndrome) J Pediatr. 1974; 85: 873–4. [PubMed] [Google Scholar]
24
25. Abe K, Ishikawa N, Murakami Y. Goldenhar's syndrome associated with cardiac malformations. Helvetica Paediatrica Acta. 1975; 30: 57–60. [PubMed] [Google Scholar]
25
26. Mahore A, Dange N, Nama S, Goel A. Facio-auriculo-vertebro-cephalic spectrum of Goldenhar syndrome. Neurol India. 2010; 58: 141–144. [PubMed] [Google Scholar]
26
27. Bielicka B, Necka A, Andrych M. Interdisciplinary treatment of patients with Goldenhar syndrome–clinical reports. Dent Med Probl. 2006; 43: 458–462. [Google Scholar]
27
28. Mehta B, Nayak C, Savant S, Amladi S. Goldenhar syndrome with unusual features. Indian J Dermatol Venereol Leprol. 2008; 74: 254–256. [PubMed] [Google Scholar]
28
29. Volpe P, Gentile M. Three-dimensional diagnosis of Goldenhar syndrome. Ultrasound Obstet Gynecol. 2004; 24: 798–800. [PubMed] [Google Scholar]
29
30. Emtiaz S, Noroozi S, Caramês J, Fonseca L. Alveolar vertical distraction osteogenesis: historical and biologic review and case presentation. Int J Periodontics Restorative Dent. 2006; 26: 529–541. [PubMed] [Google Scholar]
30
31. Sharma JK, Pippal SK, Raghuvanshi SK, Shitij A. Goldenhar-Gorlin's syndrome: A case report. Indian J Otolaryngol Head Neck Surg. 2006; 58: 97–101. [PMC free article] [PubMed] [Google Scholar]
31
ORIGINAL_ARTICLE
Mandibular Mural Ameloblastoma with Unusual Histopathologic Features: a Rare Challenging Case
Ameloblastomas demonstrate various clinical and microscopic patterns. They typically have been described as possessing three biologic variants including solid, cystic (unicystic) and peripheral, of which about 13% to 21% of all cases are unicystic. Granular cell subtype is a rare variant especially when both the inner and peripheral layers of tumoral islands composed exclusively of eosinophilic granular cells. The purpose of this case report is to present a unique case of cystic ameloblastoma with an unusual radiographic and microscopic pattern affecting a 25-year-old female. Awareness of these rare histopathologic features for oral pathologist is essential to help correct diagnosis.
https://dentjods.sums.ac.ir/article_44907_dc4c3931d8f7e1fc773558ff137e0430.pdf
2019-12-01
304
307
10.30476/dentjods.2019.44907
Ameloblastoma ● Oral Neoplasm ● Odontogenic tumor ● Mandible
Soudabeh
Sargolzaei
soudabehsargolzaei@yahoo.com
1
Dept. of Oral and Maxillofacial Pathology, Dental School, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
AUTHOR
Saede
Atarbashi-Moghadam
2
Dept. of Oral and Maxillofacial Pathology, Dental School, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
LEAD_AUTHOR
Aliasghar
Roohi
aaroohi@gmail.com
3
Oral and Maxillofacial Surgen, Tehran, Iran.
AUTHOR
1. Argyris PP, McBeain MJ, Rake A, Pambuccian SE, Gopalakrishnan R, Koutlas IG. Recurrent ameloblastoma of the mandible with unusual granular cell component. Int J Surg Pathol. 2015; 23: 298–304. [PubMed] [Google Scholar]
1
2. Matsushita Y, Fujita S, Kawasaki G, Hirota Y, Rokutanda S, Yamashita K, et al. Granular cell ameloblastoma: case report of particular ameloblastoma histologicallyresembling oncocytoma. Pathol Int. 2015; 65: 43–47. [PubMed] [Google Scholar]
2
3. Thillaikarasi R, Balaji J, Gupta B, Ilayarja V, Vani NV, Vidula B, et al. Cystic granular cell ameloblastoma. J Maxillofac Oral Surg. 2010; 9: 310–313. [PMC free article] [PubMed] [Google Scholar]
3
4. Jain K, Sharma G, Kardam P, Mehendiratta M. Unicystic Ameloblastoma of Mandible with an Unusual Diverse Histopathology: A Rare Case Report. J Clin Diagn Res. 2017; 11: ZD04–ZD05. [PMC free article] [PubMed] [Google Scholar]
4
5. Neville BW, Damm DD, Allen CM, Chi AC. Oral and Maxillofacial Pathology. Odontogenic cysts and tumors. 4rd ed. Philadelphia : Saunders; 2016. pp. 654–660. [Google Scholar]
5
6. Oza N, Agrawal K. Granular cell ameloblastoma mimicking oncocytoma. J Oral Maxillofac Pathol. 2012; 16: 446–449. [PMC free article] [PubMed] [Google Scholar]
6
7. Fujimaki M, Fukumura Y, Saito T, Mitani K, Uchida S, Yokoyama J, et al. Oncocytic mucoepidermoid carcinoma of the parotid gland with CRTC1-MAML2 fusiontranscript: report of a case with review of literature. Hum Pathol. 2011; 42: 2052–2055. [PubMed] [Google Scholar]
7
8. Atarbashi Moghadam S, Atarbashi Moghadam F, Mokhtari S, Eini E. Immunohistochemical analysis of P63 expression in odontogenic lesions. Biomed Res Int. 2013; 2013: 624176. [PMC free article] [PubMed] [Google Scholar]
8
9. Sams RN, Gnepp DR. P63 expression can be used in differential diagnosis of salivary gland acinic cell and mucoepidermoid carcinomas. Head Neck Pathol. 2013; 7: 64–68. [PMC free article] [PubMed] [Google Scholar]
9
10. Olimid DA, Florescu AM, Cernea D, Georgescu CC, Mărgăritescu C, Simionescu CE, et al. The evaluation of p16 and Ki67 immunoexpression in ameloblastomas. Rom J Morphol Embryol. 2014; 55: 363–367. [PubMed] [Google Scholar]
10